image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
d460898c0ad43e0072a01029a9c01acdda3e7621c79d1c3040cb67486516544e.png | complex | <table><tr><td>Year</td><td>Main Objetive</td><td>Assay Employed</td><td>Reference</td></tr><tr><td colspan="4">In vitro studies</td></tr><tr><td>2014</td><td>Effect of MGN on gamma radiation-induced DNA damage in human lymphocytes and lymphoblastoid cells.</td><td>Comet assay</td><td>[74]</td></tr><tr><td>2012</td><td... | <table><tr><td>Year</td><td>Main Objetive</td><td>Assay Employed</td><td>Reference</td></tr><tr><td colspan="4">In vitro studies</td></tr><tr><td>2014</td><td>Effect of MGN on gamma radiation-induced DNA damage in human lymphocytes and lymphoblastoid cells.</td><td>Comet assay</td><td>[74]</td></tr><tr><td>2012</td><td... | <table><tr><td>Year</td><td>Main Objetive</td><td>Assay Employed</td><td>Reference</td></tr><tr><td>2011</td><td>Evaluation of the protector effect of MGN against methylmercury (MeHg) induced neurotoxicity by employing IMR-32 (human neuroblastoma) cell line.</td><td>Comet assay & Micronucleus</td><td>[77]</td></tr><tr>... |
291da7d3f2b48403f2821744a65bd26e957ec73993de79a5ad31946cc1f61c9a.png | simple | <table><tr><td>Age group</td><td>No. negative</td><td>No. positive</td><td>positive (%)</td></tr><tr><td>3 to 10</td><td>201</td><td>11</td><td>5.19</td></tr><tr><td>11 to 15</td><td>346</td><td>11</td><td>3.08</td></tr><tr><td>16 to 20</td><td>702</td><td>21</td><td>2.90</td></tr><tr><td>21 to 30</td><td>1116</td><td>... | <table><tr><td>Age group</td><td>No. negative</td><td>No. positive</td><td>positive (%)</td></tr><tr><td>3 to 10</td><td>201</td><td>11</td><td>5.19</td></tr><tr><td>11 to 15</td><td>346</td><td>11</td><td>3.08</td></tr><tr><td>16 to 20</td><td>702</td><td>21</td><td>2.90</td></tr><tr><td>21 to 30</td><td>1116</td><td>... | <table><tr><td>Grand total</td><td>4154</td><td>209</td><td>4.8</td></tr></table> |
2352996350386baa3191ac351e3a5640e5e439f090fd666eb9e32e68ec3b32ca.png | complex | <table><tr><td rowspan="3"></td><td colspan="2">RMSE</td></tr><tr><td>EKF</td><td>BD-AEKF</td></tr><tr><td>Heading (degree)</td><td>1.0069</td><td>0.3751</td></tr><tr><td>Pitch (degree)</td><td>0.6812</td><td>0.1453</td></tr><tr><td>Roll (degree)</td><td>0.6488</td><td>0.1466</td></tr><tr><td>East position (m)</td><td>... | <table><tr><td></td><td colspan="2">RMSE</td></tr></table> | <table><tr><td rowspan="2"></td><td>EKF</td><td>BD-AEKF</td></tr><tr><td colspan="2"></td></tr><tr><td>Heading (degree)</td><td>1.0069</td><td>0.3751</td></tr><tr><td>Pitch (degree)</td><td>0.6812</td><td>0.1453</td></tr><tr><td>Roll (degree)</td><td>0.6488</td><td>0.1466</td></tr><tr><td>East position (m)</td><td>0.82... |
467dd24f7533ab096812b77aa3456c5a096f74d01f2de1a4a61e75c6adcdbb0e.png | complex | <table><tr><td><i>Ownership</i></td><td><i>n(%)</i></td></tr><tr><td>Household owning nets</td><td>638(95.2)</td></tr><tr><td>Households without nets</td><td>32(4.8)</td></tr><tr><td>Total</td><td>670(100)</td></tr><tr><td><i>No. of bed nets</i></td><td><i>No. of HH(%)</i></td></tr><tr><td>0</td><td>32(4.8)</td></tr><t... | <table><tr><td>Ownership</td></tr><tr><td>Household owning nets</td></tr><tr><td>Households without nets</td></tr><tr><td>Total</td></tr><tr><td>No. of bed nets</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5+</td></tr><tr><td>Total</td></tr><tr><td>Mean... | <table><tr><td>n(%)</td></tr><tr><td>638(95.2)</td></tr><tr><td>32(4.8)</td></tr><tr><td>670(100)</td></tr><tr><td>No. of HH(%)</td></tr><tr><td>32(4.8)</td></tr><tr><td>120(17.9)</td></tr><tr><td>244(36.4)</td></tr><tr><td>147(21.9)</td></tr><tr><td>88(13.1)</td></tr><tr><td>39(5.8)</td></tr><tr><td>670(100)</td></tr>... |
33ee493dc3ccba7be30fc2b1e51e8604743c6217135b3779fb3a6113326285d4.png | simple | <table><tr><td>Rank</td><td>Symptoms</td><td>Rate of patients with the symptom</td><td>Rate of patients with high PeCDF (> 50 pg/g lipids)</td></tr><tr><td>1</td><td>Black comedones (trunk) <+ or severer></td><td>0.0671</td><td>0.6563</td></tr><tr><td>2</td><td>uric acid (high)</td><td>0.1761</td><td>0.6310*</... | <table><tr><td>Rank</td><td>Symptoms</td><td>Rate of patients with the symptom</td><td>Rate of patients with high PeCDF (> 50 pg/g lipids)</td></tr></table> | <table><tr><td>1</td><td>Black comedones (trunk) <+ or severer></td><td>0.0671</td><td>0.6563</td></tr><tr><td>2</td><td>uric acid (high)</td><td>0.1761</td><td>0.6310*</td></tr><tr><td>3</td><td>Black comedones (face) <+ or severer></td><td>0.0860</td><td>0.6098</td></tr><tr><td>4</td><td>Third quartile age</td><td>0.... |
a70fab74927ecf0f1bd88880082c177431aeb0fc88fa8533a0a82fb42e275118.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="3">IntraobserverObserver 1</td><td colspan="3">IntraobserverObserver 2</td><td colspan="3">InterobserverOver assessments 1</td></tr><tr><td>ICC</td><td>Agreement (in %) </td><td>95% CI</td><td>ICC</td><td>Agreement (in %)</td><td>95% CI</td><td>ICC</td><td>Agreement (in ... | <table><tr><td rowspan="2">Item</td><td colspan="3">IntraobserverObserver 1</td><td colspan="3">IntraobserverObserver 2</td><td colspan="3">InterobserverOver assessments 1</td></tr><tr><td>ICC</td><td>Agreement (in %)</td><td>95% CI</td><td>ICC</td><td>Agreement (in %)</td><td>95% CI</td><td>ICC</td><td>Agreement (in %... | <table><tr><td>(Q1) Frowning</td><td>0.64</td><td>82.3</td><td>0.56–0.71</td><td>0.48</td><td>74.7</td><td>0.38–0.57</td><td>0.50</td><td>75.5</td><td>0.40–0.59</td></tr><tr><td>(Q2) Narrowing or closing eyes</td><td>0.68</td><td>84.0</td><td>0.61–0.74</td><td>0.31</td><td>69.6</td><td>0.19–0.42</td><td>0.25</td><td>62... |
88995dabab71c8674c23f421a7bc4908da67c01937871776138593065c061afd.png | simple | <table><tr><td>Protocol</td><td>Denaturation</td><td>Touchdown annealing cycles</td><td>Additional annealing cycles</td><td>Extension</td><td>Final extension</td></tr><tr><td>GP5+/GP6+</td><td>1 min, 94°C</td><td>-</td><td>2 min, 40°C (40–50 cycles)</td><td>1.5 min, 72°C</td><td>4 min, 72°C</t... | <table><tr><td>Protocol</td><td>Denaturation</td><td>Touchdown annealing cycles</td><td>Additional annealing cycles</td><td>Extension</td><td>Final extension</td></tr><tr><td>GP5+/GP6+</td><td>1 min, 94°C</td><td>-</td><td>2 min, 40°C (40–50 cycles)</td><td>1.5 min, 72°C</td><td>4 min, 72°C</td></tr></table> | <table><tr><td>Protocol</td><td>Denaturation</td><td>Touchdown annealing cycles</td><td>Additional annealing cycles</td><td>Extension</td><td>Final extension</td></tr><tr><td>TDP1</td><td>1 min, 94°C</td><td>2 min, 45°C to 40°C in 0.5°C decrements (11 cycles)</td><td>2 min, 40°C (29–39 cycles)</td><td>1.5 min, 72°C</td... |
70ecd44d511913d4389f8a03285e910ceae6a767b6c7e9108c6d54010fb79687.png | simple | <table><tr><td>Characteristic</td><td>HR</td><td>95% CI</td></tr><tr><td>Male sex</td><td>1.39</td><td>1.06–1.81</td></tr><tr><td>Age, per 10-year increment</td><td>1.09</td><td>1.07–1.10</td></tr><tr><td>Smoking</td><td>1.34</td><td>1.03–1.76</td></tr><tr><td>Drinking</td><td>1.03</td><td>0.81–... | <table><tr><td>Characteristic</td></tr><tr><td>Male sex</td></tr><tr><td>Age, per 10-year increment</td></tr><tr><td>Smoking</td></tr><tr><td>Drinking</td></tr><tr><td>Obesity</td></tr><tr><td>Hypertension</td></tr><tr><td>Dyslipidemia</td></tr><tr><td>Diabetes mellitus</td></tr><tr><td>AF</td></tr></table> | <table><tr><td>HR</td><td>95% CI</td></tr><tr><td>1.39</td><td>1.06–1.81</td></tr><tr><td>1.09</td><td>1.07–1.10</td></tr><tr><td>1.34</td><td>1.03–1.76</td></tr><tr><td>1.03</td><td>0.81–1.31</td></tr><tr><td>0.96</td><td>0.75–1.23</td></tr><tr><td>2.65</td><td>2.11–3.31</td></tr><tr><td>1.08</td><td>0.87–1.35</td></t... |
42d44c89ee37e67c8db8f994e277d91e7fcbab6455fee9b84817d39e3404180f.png | simple | <table><tr><td>Time (h)</td><td><i>p</i>NO<sub>2</sub>PheDU<sup>a</sup> (mM)</td><td>Conversion (%)</td></tr><tr><td>0</td><td>1.94 ± 0.03</td><td>–</td></tr><tr><td>1</td><td>1.63 ± 0.05</td><td>16</td></tr><tr><td>2</td><td>1.29 ± 0.04</td><td>34</td></tr><tr><td>3</td><td>1.24 ± 0.02</td><t... | <table><tr><td>Time (h)</td><td>pNO2PheDUa (mM)</td><td>Conversion (%)</td></tr><tr><td>0</td><td></td><td></td></tr></table> | <table><tr><td></td><td>1.94 ± 0.03</td><td>–</td></tr><tr><td>1</td><td>1.63 ± 0.05</td><td>16</td></tr><tr><td>2</td><td>1.29 ± 0.04</td><td>34</td></tr><tr><td>3</td><td>1.24 ± 0.02</td><td>36</td></tr><tr><td>4</td><td>1.18 ± 0.04</td><td>39</td></tr><tr><td>5</td><td>1.16 ± 0.11</td><td>40</td></tr><tr><td>24</td>... |
ad2f149ce48fb360b61edae19876361a2547fb2ea7e83f07d5425f775c513f48.png | simple | <table><tr><td></td><td>t0 control</td><td>t0 inoculated</td><td>t1 control</td><td>t1 inoculated</td><td>t2 control</td><td>t2 inoculated</td></tr><tr><td>Resistance to antibiotics and toxic compounds</td><td>80.7</td><td>81.4</td><td>78.9</td><td>78.8</td><td>79.7</td><td>79.8</td></tr><tr><td>–</td><td>9.7</td... | <table><tr><td></td></tr><tr><td>Resistance to antibiotics and toxic compounds</td></tr><tr><td>–</td></tr><tr><td>Multi locus sequence typing</td></tr><tr><td>Adhesion</td></tr><tr><td>Bacteriocins, ribosomally synthesized antibacterial peptides</td></tr><tr><td>Invasion and intracellular resistance</td></tr><tr><td>T... | <table><tr><td>t0 control</td><td>t0 inoculated</td><td>t1 control</td><td>t1 inoculated</td><td>t2 control</td><td>t2 inoculated</td></tr><tr><td>80.7</td><td>81.4</td><td>78.9</td><td>78.8</td><td>79.7</td><td>79.8</td></tr><tr><td>9.7</td><td>9.1</td><td>10.3</td><td>10.2</td><td>10.4</td><td>10.2</td></tr><tr><td>7... |
8a0bc3cf52b515b097bc6b58d5c4889c1fde7e29b18e4a7d22c6e67039a798b3.png | complex | <table><tr><td><i>Baseline Characteristics (at time of diagnosis)</i></td><td><i>Mean ± SD or N (%)</i></td></tr><tr><td>Age (Years)</td><td>37.41 ± 10.14</td></tr><tr><td colspan="2"><i>Gender</i></td></tr><tr><td> Male</td><td>14 (66.7%)</td></tr><tr><td> Female</td><td>07 (33.3%)</td></tr><tr><td colspan="... | <table><tr><td>Baseline Characteristics (at time of diagnosis)</td><td>Mean ± SD or N (%)</td></tr><tr><td>Age (Years)</td><td>37.41 ± 10.14</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>Male</td><td>14 (66.7%)</td></tr><tr><td>Female</td><td>07 (33.3%)</td></tr><tr><td colspan="2">Stage of Disease</td></tr><tr>... | <table><tr><td>Normal</td><td>03 (14.3%)</td></tr><tr><td colspan="2">Extra Nodal site involvement</td></tr><tr><td>None</td><td>5 (23.8%)</td></tr><tr><td>Yes</td><td>16 (76.2%)</td></tr><tr><td colspan="2">Bulky Disease</td></tr><tr><td>Yes</td><td>5 (23.8%)</td></tr><tr><td>No</td><td>16 (76.2%)</td></tr><tr><td col... |
e2d7bdc44eaaf6c996d2c44d32272f06579a7d4c6e2c6f8f1d026b45a259f000.png | complex | <table><tr><td colspan="2"><i>Variables</i></td><td><i>N</i></td><td><i>%</i></td></tr><tr><td rowspan="2"><i>Gender</i></td><td>Male</td><td>29</td><td>58</td></tr><tr><td>Female</td><td>21</td><td>42</td></tr><tr><td rowspan="2"><i>Educational level</i></td><td>Basic science (pre-clinical) years</td><td>12</td><td>24... | <table><tr><td colspan="2">Variables</td><td>N</td><td>%</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>29</td><td>58</td></tr><tr><td>Female</td><td>21</td><td>42</td></tr><tr><td rowspan="2">Educational level</td><td>Basic science (pre-clinical) years</td><td>12</td><td>24</td></tr><tr><td>Clinical years</t... | <table><tr><td rowspan="2">esearch exposure</td><td>ted in ≥ 1 research activity</td><td></td><td></td></tr><tr><td>No previous research exposure</td><td>19</td><td>38</td></tr><tr><td rowspan="2">Frequency of online search for evidence</td><td>≥ once per week</td><td>16</td><td>32</td></tr><tr><td>< once per week, or ... |
3b355d1d44a3c08bd8bd628c3ebc034aa6b06a363cc2745e1e86c57e78313cf0.png | complex | <table><tr><td>Characteristics</td><td>Patients (P, <i>n</i>=131)</td><td colspan="3">Spousal caregivers (SC, <i>n</i>=131)</td></tr><tr><td></td><td><i>n</i> (%)</td><td colspan="3"><i>n</i> (%)</td></tr><tr><td>Age (mean± SD), years</td><td>56.6±12.1 (ranging from 25 to 79)</td><td colspan="3">56.0±11.... | <table><tr><td>Characteristics</td><td>Patients (P, n=131)</td><td>Spousal caregivers (SC, n=131)</td></tr><tr><td></td><td>n (%)</td><td>n (%)</td></tr><tr><td>Age (mean± SD), years</td><td>56.6±12.1 (ranging from 25 to 79)</td><td>56.0±11.3 (ranging from 29 to 80)</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>... | <table><tr><td colspan="2">Spousal caregivers (SC, n=131)</td></tr><tr><td colspan="2">n (%)</td></tr><tr><td colspan="2">56.0±11.3 (ranging from 29 to 80)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td colspan="2">Level of education</td></tr><tr><td></td><td>... |
b7f95da801e5c941833d48659c2194441fb0bd77b2396a91b926a61db994c384.png | simple | <table><tr><td>Characteristic</td><td>TeleWii Group (<i>n</i> = 38)</td><td>SIBT group (<i>n</i> = 38)</td><td>Baseline comparison <i>p</i> value</td></tr><tr><td>Age (years) (mean ± SD)</td><td>67.45 (7.18)</td><td>69.84 (9.41)</td><td>0.14</td></tr><tr><td>Gender (number of males/females)</td><td>23/15</td><td>2... | <table><tr><td>Characteristic</td><td>TeleWii Group (n = 38)</td><td>SIBT group (n = 38)</td><td>Baseline comparison p value</td></tr></table> | <table><tr><td>Age (years) (mean ± SD)</td><td>67.45 (7.18)</td><td>69.84 (9.41)</td><td>0.14</td></tr><tr><td>Gender (number of males/females)</td><td>23/15</td><td>28/10</td><td>0.22</td></tr><tr><td>Disease duration (years) (mean ± SD)</td><td>6.16 (3.81)</td><td>7.47 (3.90)</td><td>0.14</td></tr><tr><td>Dominant PD... |
0504431b2c64ae52308862eda77b0aceb8071dc113fa6e2b78de65467826a366.png | complex | <table><tr><td> </td><td colspan="3">Johannesburg<sup>**</sup></td><td colspan="3">Cape town</td><td colspan="3">Rustenburg</td></tr><tr><td> </td><td>Surveys<sup>#</sup></td><td>FGDs<sup>^</sup></td><td>Diaries</td><td>Surveys<sup>#</sup></td><td>FGDs<sup>*</sup></td><td>Diaries</td><td>Surveys<sup>#</sup></td><td>FGD... | <table><tr><td></td><td colspan="3">Johannesburg**</td><td colspan="3">Cape town</td></tr><tr><td></td><td>Surveys#</td><td>FGDs^</td><td>Diaries</td><td>Surveys#</td><td>FGDs*</td><td>Diaries</td></tr><tr><td>Pre-World Cup</td><td>-</td><td>2</td><td>-</td><td>-</td><td>2</td><td>-</td></tr><tr><td>World Cup</td><td>3... | <table><tr><td colspan="3">Rustenburg</td></tr><tr><td>Surveys#</td><td>FGDs^</td><td>Diaries</td></tr><tr><td>-</td><td>1</td><td>-</td></tr><tr><td>123 (91%)</td><td>1</td><td>8</td></tr><tr><td>102 (88%)</td><td>1</td><td>8</td></tr></table> |
f5e551ab0c7280bbe509cfd541038b40eb73225902c4fa6bce98ff0e72ea2c43.png | complex | <table><tr><td rowspan="2">Variables</td><td>Total</td><td>First-year</td><td>Fifth-year</td><td rowspan="2">p<sup>c</sup></td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td colspan="5">Sociodemographic</td></tr><tr><td> Age<sup>a</sup></td><td>20.4 (3.0)</td><td>19.0 (2.0)</td><td>23.2 (2.3)</td><td>&... | <table><tr><td rowspan="2">Variables</td><td>Total</td><td>First-year</td><td>Fifth-year</td><td rowspan="2">pc</td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td colspan="5">Sociodemographic</td></tr><tr><td>Agea</td><td>20.4 (3.0)</td><td>19.0 (2.0)</td><td>23.2 (2.3)</td><td><0.001d</td></tr><tr><td... | <table><tr><td rowspan="2">Variables</td><td>Total</td><td>First-year</td><td>Fifth-year</td><td rowspan="2">pc</td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>ender</td><td>)</td><td>(46.6)</td><td>(48.6)</td><td></td></tr><tr><td>Married/cohabiting</td><td>364 (3.3)</td><td>153 (2.1)</td><td>211 (... |
c8d1f99c5e8f154ad973caef2aa0c45dda06b12f928a01cbf00f10315f966b0e.png | complex | <table><tr><td colspan="2"> </td></tr><tr><td>Severe disability</td><td>Any severe cerebral palsy (child non-ambulant and likely to remain so; GMFCS level 4 or 5), severe developmental delay (standardised score <−3 SD) or blindness.</td></tr><tr><td>Moderate disability</td><td>Moderate cerebral palsy (child no... | <table><tr><td colspan="2"></td></tr><tr><td>Severe disability</td><td>Any severe cerebral palsy (child non-ambulant and likely to remain so; GMFCS level 4 or 5), severe developmental delay (standardised score <−3 SD) or blindness.</td></tr><tr><td>Mod</td><td>Moderate cerebral palsy (child non-ambulant at 2 years of a... | <table><tr><td colspan="2"></td></tr><tr><td>erate disability</td><td> SD).</td></tr><tr><td>Mild disability</td><td>Mild cerebral palsy (child walking at 2 years of age with only minimal limitation of movement (GMFCS level 1), or suspect developmental delay (standardised score from −2 SD to <−1 SD).</td></tr><tr><td>N... |
17a7e08c20dcbcacf9e0c73b6081986cf1cd6400886bdc1cb464fad0bef4ddf5.png | simple | <table><tr><td>What influences the decision about prenatal examinations?</td><td></td></tr><tr><td><i>n</i> = 302</td><td><i>n (%)</i></td></tr><tr><td>Worry about the health of the baby</td><td>268 (89)</td></tr><tr><td>I want to know as much as possible</td><td>117 (39)</td></tr><tr><td>No reasons to refuse</td><td>8... | <table><tr><td>What influences the decision about prenatal examinations?</td><td></td></tr><tr><td>n = 302</td><td>n (%)</td></tr><tr><td>Worry about the health of the baby</td><td>268 (89)</td></tr><tr><td>I want to know as much as possible</td><td>117 (39)</td></tr><tr><td>No reasons to refuse</td><td>81 (27)</td></t... | <table><tr><td>What influences the decision about prenatal examinations?</td><td></td></tr><tr><td> gender of the baby</td><td> (1)</td></tr><tr><td>Who influences the decision about prenatal examinations?</td><td></td></tr><tr><td>n = 302</td><td></td></tr><tr><td>My partner</td><td>250 (83)</td></tr><tr><td>The docto... |
e4d99f82f9fd710cb70f13a980a399021669128f9e56d5641a920e831058063f.png | complex | <table><tr><td></td><td></td><td>Crude ORs<sup>ab</sup></td><td>95% CI<sup>c</sup></td><td><i>p</i>-value</td><td colspan="2">Adjusted ORs<sup>d</sup></td><td colspan="2">95% CI</td><td><i>p</i>-value</td></tr><tr><td>Age</td><td>≥30 years</td><td>(reference)</td><td></td><td></td><td colspan="2">(reference)</td>... | <table><tr><td></td><td></td><td>Crude ORsab</td><td>95% CIc</td><td>p-value</td><td colspan="2">Adjusted ORsd</td><td colspan="2">95% CI</td><td>p-value</td></tr><tr><td>Age</td><td>≥30 years</td><td>(reference)</td><td></td><td></td><td colspan="2">(reference)</td><td colspan="2"></td><td></td></tr><tr><td></td><td><... | <table><tr><td>Key person</td><td>No</td><td>(reference)</td><td></td><td></td><td colspan="2">(reference)</td><td colspan="2"></td><td></td></tr><tr><td></td><td>Yes</td><td>0.80</td><td>0.45-1.41</td><td>0.438</td><td colspan="2">0.58</td><td colspan="2">0.28-1.19</td><td>0.135</td></tr><tr><td>Route of infection</td... |
00c9fe158868908f0bc3bdf236600848124167ab0c2fe149f934890470d725cc.png | simple | <table><tr><td>Vascular smooth muscle cells</td><td>Respiratory epithelial cells</td></tr><tr><td>Viability for different pressures (0, 0.4, 0.8, 1.2, 1.6, 2 bar)</td><td>Viability (0.4 bar)</td></tr><tr><td>Viability for different velocities (10, 30, 55, 75, 95 mL/min)</td><td>Short-term differentiation (pan-cytokerat... | <table><tr><td>Vascular smooth muscle cells</td><td>Respiratory epithelial cells</td></tr><tr><td>Viability for different pressures (0, 0.4, 0.8, 1.2, 1.6, 2 bar)</td><td>Viability (0.4 bar)</td></tr><tr><td>Viability for different velocities (10, 30, 55, 75, 95 mL/min)</td><td>Short-term differentiation (pan-cytokerat... | <table><tr><td>Short-term differentiation (α-SMA expression)</td><td>Long-term differentiation (14 and 28 days: pan-cytokeratin expression and PAS reaction)</td></tr></table> |
ebc327f8d28fe5c5ec353028175930d86bf3e85622c6b73461980f516b5d9781.png | simple | <table><tr><td><i>p</i> (FWEcorr)</td><td>T</td><td>Z</td><td>Coordinates x, y, z {mm} max. peak</td><td>Brain area</td></tr><tr><td>0.003843</td><td>7.936576</td><td>4.986516</td><td>18, 36, −8</td><td>Right medial orbitofrontal cortex</td></tr></table> | <table><tr><td>p (FWEcorr)</td><td>T</td><td>Z</td><td>Coordinates x, y, z {mm} max. peak</td><td>Brain area</td></tr></table> | <table><tr><td>0.003843</td><td>7.936576</td><td>4.986516</td><td>18, 36, −8</td><td>Right medial orbitofrontal cortex</td></tr></table> |
dd084dbbacb84a96f6e4d39f95fd8cee9c026a49a2873065e80b24bd2edc64bb.png | simple | <table><tr><td>Economic interventions</td><td>Definition</td><td>Search terms</td></tr><tr><td>Price Interventions - Taxes and Subsidies</td><td>Interventions that target prices for goods and services paid/received by households or firms</td><td>“tax”, “subsidy”, “subsidized”, “... | <table><tr><td>Economic interventions</td><td>Definition</td><td>Search terms</td></tr></table> | <table><tr><td>Price Interventions - Taxes and Subsidies</td><td>Interventions that target prices for goods and services paid/received by households or firms</td><td>“tax”, “subsidy”, “subsidized”, “subsidies”, “penalty”, “penalties”, “voucher”, “vouchers”</td></tr><tr><td>Income Transfer Programs</td><td>Interventions... |
92f796b72b00a6b102886a8f13b0bac9ddc5212974c9d1cd64fee1369b17fef5.png | simple | <table><tr><td>Variables</td><td>Negative AV</td><td>Positive AV</td><td><i>P</i> value</td></tr><tr><td>Failure rate (%)</td><td>36.8</td><td>81.2</td><td>0.016*<sup>,b</sup></td></tr><tr><td>Surgical rate (%)</td><td>21.1</td><td>75.0</td><td>0.002*<sup>,b</sup></td></tr><tr><td>AV at PHV (°/y)</td><td>−9.... | <table><tr><td>Variables</td><td>Negative AV</td></tr><tr><td>Failure rate (%)</td><td>36.8</td></tr><tr><td>Surgical rate (%)</td><td>21.1</td></tr><tr><td>AV at PHV (°/y)</td><td>−9.6 ± 7.6</td></tr><tr><td>Initial curve magnitude (°)</td><td>26.3 ± 4.6</td></tr><tr><td>Final curve magnitude (°)</td><td>29.4 ± 9.1</t... | <table><tr><td>Positive AV</td><td>P value</td></tr><tr><td>81.2</td><td>0.016*,b</td></tr><tr><td>75.0</td><td>0.002*,b</td></tr><tr><td>8.2 ± 4.0</td><td>0.000*,a</td></tr><tr><td>26.7 ± 5.7</td><td>0.832</td></tr><tr><td>39.6 ± 14.2</td><td>0.015*,a</td></tr><tr><td>9.4 ± 1.8</td><td>0.327</td></tr><tr><td>11.5 ± 0.... |
5418cb7071169c0ff80b85923501892780e114e693c3a243ca96da27643937fa.png | simple | <table><tr><td> </td><td>Paucigranulocytic phenotype</td><td>Eosinophilic phenotype</td><td>Neutrophilic phenotype</td><td>Mixed granulocytic phenotype</td></tr><tr><td>Steroid naïve (n = 153)</td><td>65 (42.5%)</td><td>60 (39.2%)</td><td>25 (16.3%)</td><td>3 (2%)</td></tr><tr><td>Steroid-treated (n = 355)</td><t... | <table><tr><td></td><td>Paucigranulocytic phenotype</td><td>Eosinophilic phenotype</td><td>Neutrophilic phenotype</td></tr><tr><td>Steroid naïve (n = 153)</td><td>65 (42.5%)</td><td>60 (39.2%)</td><td>25 (16.3%)</td></tr><tr><td>Steroid-treated (n = 355)</td><td>138 (38%)</td><td>151 (43%)</td><td>55 (15%)</td></tr></... | <table><tr><td>Mixed granulocytic phenotype</td></tr><tr><td>3 (2%)</td></tr><tr><td>11 (3%)*</td></tr></table> |
25059de33224b2dcfd393bad8a64cd19778f0a6305f37ddce82ef24e72bcd871.png | complex | <table><tr><td rowspan="2" colspan="2">Level of Training</td><td colspan="6">Teaching Method</td></tr><tr><td>M</td><td>C</td><td>A</td><td>E</td><td>SLE</td><td>Total</td></tr><tr><td>Junior</td><td>Count</td><td>24</td><td>29</td><td>4</td><td>2</td><td>7</td><td>66</td></tr><tr><td></td><td>% within TM</td><td>77.4<... | <table><tr><td rowspan="2" colspan="2">Level of Training</td><td colspan="5">Teaching Method</td></tr><tr><td>M</td><td>C</td><td>A</td><td>E</td><td>SLE</td></tr><tr><td>Junior</td><td>Count</td><td>24</td><td>29</td><td>4</td><td>2</td><td>7</td></tr><tr><td></td><td>% within TM</td><td>77.4</td><td>31.5</td><td>11.8... | <table><tr><td>Teaching Method</td></tr><tr><td>Total</td></tr><tr><td>66</td></tr><tr><td>32 %</td></tr><tr><td></td></tr><tr><td>62</td></tr><tr><td>30.1 %</td></tr><tr><td></td></tr><tr><td>78</td></tr><tr><td>37.9 %</td></tr><tr><td></td></tr><tr><td>206</td></tr></table> |
f0bc60cdec5dd736300e80bd920dcaa89071f0e45f4971c0344252c7fc52f3f5.png | simple | <table><tr><td>Sample No.</td><td>HN37</td><td>HN44</td><td>HN48</td></tr><tr><td>RL2</td><td>6a</td><td>9c</td><td>8b</td></tr><tr><td>RL3</td><td>11c</td><td>10b</td><td>9a</td></tr><tr><td>SL2</td><td>9a</td><td>12c</td><td>10b</td></tr><tr><td>SL3</td><td>12a</td><td>13b</td><td>12a</td></tr></table> | <table><tr><td>Sample No.</td><td>HN37</td><td>HN44</td><td>HN48</td></tr><tr><td>RL2</td><td>6a</td><td>9c</td><td>8b</td></tr><tr><td>RL3</td><td>11c</td><td>10b</td><td>9a</td></tr></table> | <table><tr><td>Sample No.</td><td>HN37</td><td>HN44</td><td>HN48</td></tr><tr><td>SL2</td><td>9a</td><td>12c</td><td>10b</td></tr><tr><td>SL3</td><td>12a</td><td>13b</td><td>12a</td></tr></table> |
f843d74585eeb05f85fc2aa7805d8bd43033dfa3f5bf14339e78bc487729846a.png | simple | <table><tr><td></td><td>Frequency</td></tr><tr><td>’NNP’,’DISEASE’,’NNP’</td><td>36</td></tr><tr><td>’NNP’,’NNP’,’DISEASE’,’NNP’</td><td>16</td></tr><tr><td>’NNP’,’DISEASE’,’NNP’,’NNP’</td... | <table><tr><td></td></tr><tr><td>’NNP’,’DISEASE’,’NNP’</td></tr><tr><td>’NNP’,’NNP’,’DISEASE’,’NNP’</td></tr><tr><td>’NNP’,’DISEASE’,’NNP’,’NNP’</td></tr><tr><td>’IN’,’DISEASE’,’CC’</td></tr></table> | <table><tr><td>Frequency</td></tr><tr><td>36</td></tr><tr><td>16</td></tr><tr><td>11</td></tr><tr><td>10</td></tr></table> |
7098a547f74b59eb47f6e2a045997850d40c29ec68e14256f8aec386948c1447.png | complex | <table><tr><td></td><td colspan="2">Women</td><td colspan="2">Men</td><td colspan="2">Denominatorwomen</td><td colspan="2">Denominatormen</td></tr><tr><td></td><td>Per cent</td><td>CI</td><td>Per cent</td><td>CI</td><td>Unwt</td><td>Wt</td><td>Unwt</td><td>Wt</td></tr><tr><td colspan="9">Lifetime diagnoses</td></tr><tr... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Lifetime diagnoses</td></tr><tr><td>16–24</td></tr><tr><td>25–34</td></tr><tr><td>35–44</td></tr><tr><td>45–54</td></tr><tr><td>55–64</td></tr><tr><td>65–74</td></tr><tr><td>Total aged 16–44</td></tr><tr><td>Total aged 45–74</td></tr><tr><td>Total</td></tr><tr><td>Past... | <table><tr><td colspan="2">Women</td><td colspan="2">Men</td><td colspan="2">Denominatorwomen</td><td colspan="2">Denominatormen</td></tr><tr><td>Per cent</td><td>CI</td><td>Per cent</td><td>CI</td><td>Unwt</td><td>Wt</td><td>Unwt</td><td>Wt</td></tr><tr><td colspan="8">Lifetime diagnoses</td></tr><tr><td>0.1</td><td>(... |
3b4758e5ed09c238379a692c4d9a726d794219c1ddd5d3a50c9f94030461bc47.png | complex | <table><tr><td>Ergonomic instructions</td><td colspan="10">Health complaints often</td></tr><tr><td></td><td colspan="2">Eyes</td><td colspan="2">Neck, shoulders</td><td colspan="2">Head</td><td colspan="2">Hands, fingers, wrists</td><td colspan="2">Lower back</td></tr><tr><td></td><td>n*</td><td>OR (95%Cl)</td><td>N</... | <table><tr><td>Ergonomic instructions</td><td colspan="8">Health complaints often</td></tr><tr><td></td><td colspan="2">Eyes</td><td colspan="2">Neck, shoulders</td><td colspan="2">Head</td><td colspan="2">Hands, fingers, wrists</td></tr><tr><td></td><td>n*</td><td>OR (95%Cl)</td><td>N</td><td>OR (95%Cl)</td><td>N</td>... | <table><tr><td colspan="2">Health complaints often</td></tr><tr><td colspan="2">Lower back</td></tr><tr><td>N</td><td>OR (95%Cl)</td></tr><tr><td>82</td><td>1.2 (0.8-1.9)</td></tr><tr><td>95</td><td>1.4 (0.9-2.3)</td></tr></table> |
4f8448c4e7da2d6618149612cb37b6c026a4112651e366e598893b59d3bb24ba.png | complex | <table><tr><td>Characteristic</td><td>Total</td></tr><tr><td>Patients, N</td><td>448</td></tr><tr><td colspan="2">HAE diagnosis, n (%)</td></tr><tr><td> Type 1</td><td>423 (94.4)</td></tr><tr><td> Type 2</td><td>25 (5.6)</td></tr><tr><td colspan="2">Sex, n (%)</td></tr><tr><td> Female</td><td>263 (58.7)</td></tr><tr><t... | <table><tr><td>Characteristic</td><td>Total</td></tr><tr><td>Patients, N</td><td>448</td></tr><tr><td colspan="2">HAE diagnosis, n (%)</td></tr><tr><td>Type 1</td><td>423 (94.4)</td></tr><tr><td>Type 2</td><td>25 (5.6)</td></tr><tr><td colspan="2">Sex, n (%)</td></tr><tr><td>Female</td><td>263 (58.7)</td></tr><tr><td>M... | <table><tr><td colspan="2">Age at enrollment, y</td></tr><tr><td>Mean (SD)</td><td>40.8 (14.7)</td></tr><tr><td>Median (min, max)</td><td>39.1 (16.5, 81.8)</td></tr><tr><td colspan="2">Country, n (%)</td></tr><tr><td>France</td><td>119 (26.6)</td></tr><tr><td>Spain</td><td>69 (15.4)</td></tr><tr><td>Germany</td><td>57 ... |
490b081ee4338da0b27e5b81c79ffddca19d7a17b39b13748852fed10044b74d.png | simple | <table><tr><td>Client Characteristic</td><td>No. (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>1303 (91)</td></tr><tr><td>Male</td><td>122 (9)</td></tr><tr><td>Age, years</td><td></td></tr><tr><td><15</td><td>75 (5)</td></tr><tr><td>15–18</td><td>786 (55)</td></tr><tr><td>19–20</td><t... | <table><tr><td>Client Characteristic</td><td>No. (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>1303 (91)</td></tr><tr><td>Male</td><td>122 (9)</td></tr><tr><td>Age, years</td><td></td></tr><tr><td><15</td><td>75 (5)</td></tr><tr><td>15–18</td><td>786 (55)</td></tr><tr><td>19–20</td><td>514 (36)</td>... | <table><tr><td>Client Characteristic</td><td>No. (%)</td></tr><tr><td>2</td><td>148 (10)</td></tr><tr><td>3</td><td>14 (1)</td></tr><tr><td>5 or more</td><td>4 (0.3)</td></tr><tr><td>Marital status</td><td></td></tr><tr><td>Married or cohabiting</td><td>553 (39)</td></tr><tr><td>Single or living alone</td><td>872 (61)<... |
3d3d9920a51f3e376749246621e9e956d4d6f7975304c83f94f25230e2ca0200.png | complex | <table><tr><td></td><td colspan="2">Age</td><td colspan="2">IOP</td><td colspan="2">Number of Glaucoma Medications</td><td colspan="2">AL</td><td colspan="2">ACD</td><td colspan="2">LT</td><td colspan="2">VCD</td></tr><tr><td></td><td>ρ</td><td><i>P</i> value</td><td>ρ</td><td><i>P</i> value</td><td>ρ</t... | <table><tr><td></td><td colspan="2">Age</td><td colspan="2">IOP</td><td colspan="2">Number of Glaucoma Medications</td><td colspan="2">AL</td><td colspan="2">ACD</td><td colspan="2">LT</td><td colspan="2">VCD</td></tr><tr><td></td><td>ρ</td><td>P value</td><td>ρ</td><td>P value</td><td>ρ</td><td>P value</td><td>ρ</td><... | <table><tr><td>IL-8</td><td>−0.143</td><td>0.406</td><td>0.375</td><td>0.024</td><td>0.439</td><td>0.007*</td><td>−0.198</td><td>0.246</td><td>0.056</td><td>0.743</td><td>0.004</td><td>0.980</td><td>−0.201</td><td>0.239</td></tr><tr><td>MCP-1</td><td>−0.097</td><td>0.573</td><td>0.291</td><td>0.085</td><td>0.285</td><t... |
d8c9a73fc6bb5973608bcfe200699cb0be5d50f223c4775647a7e00049d9b65d.png | simple | <table><tr><td>Phenotype</td><td>Loci</td><td>C/C</td><td>C/R</td><td>R/R</td></tr><tr><td>BMI</td><td><i>ht1</i></td><td>518(22.34 ± 3.70)</td><td>904(22.34 ± 3.62)</td><td>454(22.35 ± 3.59)</td></tr><tr><td></td><td><i>ht2</i></td><td>584(22.39 ± 3.64)</td><td>896(22.35 ± 3.63)</td><td>396(22... | <table><tr><td>Phenotype</td><td>Loci</td><td>C/C</td><td>C/R</td><td>R/R</td></tr><tr><td>BMI</td><td>ht1</td><td>518(22.34 ± 3.70)</td><td>904(22.34 ± 3.62)</td><td>454(22.35 ± 3.59)</td></tr><tr><td></td><td>ht2</td><td>584(22.39 ± 3.64)</td><td>896(22.35 ± 3.63)</td><td>396(22.28 ± 3.62)</td></tr><tr><td></td><td>h... | <table><tr><td>Phenotype</td><td>Loci</td><td>C/C</td><td>C/R</td><td>R/R</td></tr><tr><td>HOMA_B</td><td>ht1</td><td>509(225.47 ± 126.01)</td><td>898(240.16 ± 144.09)</td><td>448(254.96 ± 200.10)</td></tr><tr><td></td><td>ht2</td><td>577(251.20 ± 186.38)</td><td>889(240.64 ± 143.02)</td><td>389(220.51 ± 128.44)</td></... |
cf2d226cfee32122649925da9c177ed66de04aa67f5d8e3441c1ecd7ba859b2e.png | simple | <table><tr><td>Terms</td><td>aklB, ada</td><td>aklB, ada, dinJ</td></tr><tr><td>DNA repair (SP-PIR)</td><td>5.1E-28</td><td></td></tr><tr><td>DNA damage (SP-PIR)</td><td>6.2E-28</td><td></td></tr><tr><td>Cellular response to stress (GO)</td><td></td><td>7.5E-23</td></tr><tr><td>DNA repair (GO)</td><td></td><td>1.6E-21<... | <table><tr><td>Terms</td><td>aklB, ada</td><td>aklB, ada, dinJ</td></tr><tr><td>DNA repair (SP-PIR)</td><td>5.1E-28</td><td></td></tr><tr><td>DNA damage (SP-PIR)</td><td>6.2E-28</td><td></td></tr></table> | <table><tr><td>Cellular response to stress (GO)</td><td></td><td>7.5E-23</td></tr><tr><td>DNA repair (GO)</td><td></td><td>1.6E-21</td></tr><tr><td>Response to DNA damage stimulus (GO)</td><td></td><td>1.6E-21</td></tr></table> |
4ca1c17aee2e46f874c4ceaf22f09e848128bef6c264e93d214f6f0e82453bb8.png | complex | <table><tr><td rowspan="2"></td><td>≤ 11.6</td><td>> 11.6</td><td></td></tr><tr><td><i>N</i> = 129</td><td><i>N</i> = 135</td><td><i>P</i>-value</td></tr><tr><td>Gender (F/M)</td><td>57/72</td><td>62/73</td><td>0.776</td></tr><tr><td>Age (yr)</td><td>28.4 ± 18.75</td><td>41.2 ± 15.58</td><td>< 0.0... | <table><tr><td rowspan="2"></td><td>≤ 11.6</td><td>> 11.6</td><td></td></tr><tr><td>N = 129</td><td>N = 135</td><td>P-value</td></tr><tr><td>Gender (F/M)</td><td>57/72</td><td>62/73</td><td>0.776</td></tr><tr><td>Age (yr)</td><td>28.4 ± 18.75</td><td>41.2 ± 15.58</td><td>< 0.001</td></tr><tr><td>Body mass index (kg/m2)... | <table><tr><td>Hemoglobin (g/L)</td><td>128.8 ± 12.80</td><td>134.3 ± 12.31</td><td>< 0.001</td></tr><tr><td>Mean corpuscular hemoglobin (pg)</td><td>27.2 ± 2.98</td><td>28.5 ± 3.07</td><td>< 0.001</td></tr><tr><td>Mean corpuscular hemoglobin concentration (g/L)</td><td>326.5 ± 10.64</td><td>326.8 ± 27.54</td><td>0.902... |
77d8034995fddc3eb8c0fd7e5f11693712bcd7c0975725fa11294391ef5f431d.png | complex | <table><tr><td>Data<sup><i>∗</i></sup></td><td>BJK recipe (<i>n</i> = 42)</td><td>Diclofenac (<i>n</i> = 42)</td><td> <i>P</i>value<sup><i>∗∗</i></sup></td></tr><tr><td>Female, number (%)</td><td>38 (90.5)</td><td>39 (92.9)</td><td>0.693<sup>c</sup></td></tr><tr><td>Age; yrs, mean (SD)</td><td>61.67 (... | <table><tr><td>Data∗</td><td>BJK recipe (n = 42)</td><td>Diclofenac (n = 42)</td><td>Pvalue∗∗</td></tr><tr><td>Female, number (%)</td><td>38 (90.5)</td><td>39 (92.9)</td><td>0.693c</td></tr><tr><td>Age; yrs, mean (SD)</td><td>61.67 (7.3)</td><td>63.5 (8.19)</td><td>0.282t</td></tr><tr><td>Weight; kg., mean (SD)</td><td... | <table><tr><td>Data∗</td><td>BJK recipe (n = 42)</td><td>Diclofenac (n = 42)</td><td>Pvalue∗∗</td></tr><tr><td>Diastolic (mm·Hg)</td><td>81.9 (9.23)</td><td>78.31 (8.5)</td><td>0.067t</td></tr><tr><td colspan="4">Renal function tests</td></tr><tr><td>BUN (mg/dL)</td><td>13.24 (3.7)</td><td>13.3 (3.4)</td><td>0.941t</td... |
2c764007bc2e8b99601930d5eef2874b7e0f012acb6e01651bcad796a7a455fc.png | complex | <table><tr><td rowspan="2">Compounds</td><td colspan="3">III Instar</td><td colspan="3">Pupae</td></tr><tr><td>LC<sub>50</sub></td><td>LC<sub> 90</sub></td><td>Chi **</td><td>LC<sub> 50</sub></td><td>LC<sub> 90</sub></td><td>Chi **</td></tr><tr><td><i>t</i>-anethole</td><td>7.4 (6.5–8.3)</td><td>18.8 (17.4–... | <table><tr><td rowspan="2">Compounds</td><td colspan="3">III Instar</td><td colspan="3">Pupae</td></tr><tr><td>LC50</td><td>LC 90</td><td>Chi **</td><td>LC 50</td><td>LC 90</td><td>Chi **</td></tr></table> | <table><tr><td>t-anethole</td><td>7.4 (6.5–8.3)</td><td>18.8 (17.4–20.2)</td><td>0.055</td><td>28.6 (26.4–30.8)</td><td>48.6 (45.79–51.51)</td><td>0.039</td></tr><tr><td>carvacrol</td><td>5.5 (5.2–5.7)</td><td>11.3 (9.9–2.7)</td><td>2.684</td><td>53.2 (49.9–56.6)</td><td>111.4 (102.0–120.8)</td><td>0.483</td></tr><tr><... |
710447d306fe663ba229a312e8feb5fb1bc3125149cf6b9b954711af59c5baef.png | complex | <table><tr><td>Genotype</td><td>Cases, n=125 (%)</td><td>Controls, n=200 (%)</td><td>Crude OR (95% CI)</td><td>Adjusteda OR (95% CI)</td></tr><tr><td colspan="5"><i>MDM2</i> SNP309</td></tr><tr><td> TT</td><td>30 (24.0)</td><td>62 (31.0)</td><td>1.00 (reference)</td><td>1.00 (reference)</td></tr><tr><td> TG</td><td>61 ... | <table><tr><td>Genotype</td><td>Cases, n=125 (%)</td><td>Controls, n=200 (%)</td><td>Crude OR (95% CI)</td><td>Adjusteda OR (95% CI)</td></tr><tr><td colspan="5">MDM2 SNP309</td></tr><tr><td>TT</td><td>30 (24.0)</td><td>62 (31.0)</td><td>1.00 (reference)</td><td>1.00 (reference)</td></tr><tr><td>TG</td><td>61 (48.8)</t... | <table><tr><td>Arg/Arg</td><td>31 (24.8)</td><td>53 (26.5)</td><td>1.06 (0.53–2.12)</td><td>1.01 (0.47–2.19)</td></tr><tr><td></td><td></td><td></td><td>P-trend=0.95</td><td>P-trend=0.98</td></tr><tr><td>Ser/Arg + Arg/Arg</td><td>104 (83.2)</td><td>162 (81.0)</td><td>1.16 (0.65–2.09)</td><td>1.09 (0.57–2.09)</td></tr><... |
06cb522567a8038be003f143f4b508fcc7fe9db3890e0e156716b3c1cfeb96b6.png | complex | <table><tr><td>Valence class/Emotion</td><td colspan="3">Europeans</td><td colspan="3">Iranians</td></tr><tr><td></td><td>β</td><td><i>T</i></td><td>Partial <i>r</i></td><td>β</td><td><i>T</i></td><td>Partial <i>r</i></td></tr><tr><td>Negative pictures</td><td></td><td></td><td></td><td></td><td></td><td></td... | <table><tr><td>Valence class/Emotion</td><td colspan="3">Europeans</td><td colspan="3">Iranians</td></tr><tr><td></td><td>β</td><td>T</td><td>Partial r</td><td>β</td><td>T</td><td>Partial r</td></tr><tr><td>Negative pictures</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Happiness</td><td>0.13</... | <table><tr><td>Disgust</td><td>0.31</td><td>5.70***</td><td>0.54</td><td>0.08</td><td>1.73</td><td>0.18</td></tr><tr><td>Positive pictures</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Happiness</td><td>0.85</td><td>14.87***</td><td>0.86</td><td>0.36</td><td>4.91***</td><td>0.51</td></tr><tr><t... |
78e1b2c07318b5a96a5b3db338e3f072178730132ff92d34df9bf07f816a0f09.png | simple | <table><tr><td>AFL</td><td>AML</td><td>Stack</td><td>Description</td></tr><tr><td>signal S</td><td>-</td><td>(--)</td><td>Definition of a signal S.</td></tr><tr><td>: $S .. ;</td><td>DEF</td><td>(arg --)</td><td>Definition of a handler for signal S. The signal argument is pushed on the top of the data stack.</td></tr><... | <table><tr><td>AFL</td><td>AML</td><td>Stack</td><td>Description</td></tr><tr><td>signal S</td><td>-</td><td>(--)</td><td>Definition of a signal S.</td></tr><tr><td>: $S .. ;</td><td>DEF</td><td>(arg --)</td><td>Definition of a handler for signal S. The signal argument is pushed on the top of the data stack.</td></tr><... | <table><tr><td>AFL</td><td>AML</td><td>Stack</td><td>Description</td></tr><tr><td>raise</td><td>RAISE</td><td>(arg sig# pid --)</td><td>Send a signal S with an argument to the process pid.</td></tr><tr><td>timer</td><td>TIMER</td><td>(sig# tmo --)</td><td>Install a timer (tmo > 0) raising signal sig if the time-out has... |
8f0d519e13ce27dfbf8df6570a99ea9c8c1a5d703e3b285fef1d5cf0ef17c82c.png | complex | <table><tr><td> </td><td colspan="2">n</td><td>% who correctly identified the firstline anti-malarial therapy</td><td>Unadjusted odds ratio (95% confidence interval; P value)</td></tr><tr><td>Malaria training</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Attended malaria workshop</td><td> </td><td> </td><td>... | <table><tr><td></td><td colspan="2">n</td><td>% who correctly identified the firstline anti-malarial therapy</td><td>Unadjusted odds ratio (95% confidence interval; P value)</td></tr><tr><td>Malaria training</td><td></td><td></td><td></td><td></td></tr><tr><td>Attended malaria workshop</td><td></td><td></td><td></td><t... | <table><tr><td></td><td colspan="2">n</td><td>% who correctly identified the firstline anti-malarial therapy</td><td>Unadjusted odds ratio (95% confidence interval; P value)</td></tr><tr><td></td><td>Yes</td><td></td><td>%</td><td>4 (0.42 - 2.07; 0.873)</td></tr><tr><td></td><td>No</td><td>66</td><td>67%</td><td>Ref</t... |
eeca671ae6424d4415409a394f1818262193e465951ae91784f830eccd06b445.png | complex | <table><tr><td rowspan="2">Link</td><td rowspan="2">Antecedent</td><td rowspan="2">Consequent</td><td rowspan="2">Measure(s) of consequent</td><td colspan="2">results</td></tr><tr><td>Link found?</td><td>Consequent (‘effect’) stronger in DLC?</td></tr><tr><td rowspan="3">A</td><td rowspan="4">DLC training (... | <table><tr><td rowspan="2">Link</td><td rowspan="2">Antecedent</td><td rowspan="2">Consequent</td><td rowspan="2">Measure(s) of consequent</td><td colspan="2">results</td></tr><tr><td>Link found?</td><td>Consequent (‘effect’) stronger in DLC?</td></tr></table> | <table><tr><td rowspan="3">A</td><td rowspan="4">DLC training (DLC sites only)</td><td rowspan="3">Staff characteristics</td><td>DAS, ADQ, SNCW</td><td>Yes</td><td>No for DAS, ADQ and parts of SNCW. Yes for SNCW Development and Patient Knowledge components.</td></tr><tr><td>Sick-leave</td><td>Yes</td><td>Yes</td></tr><... |
b48eefb983f74c663e3aef0ce501c67cc96d04304029cf1912178e0f5a8c729a.png | simple | <table><tr><td>Characteristics</td><td> </td><td>HAP (n = 94)</td><td> </td><td> </td><td>VAP (n = 117)</td><td> </td></tr><tr><td> </td><td>Adequate treatment n = 43 (%)</td><td>Inadequate treatment n = 51 (%)</td><td>p</td><td>Adequate treatment n = 37 (%)</td><td>Inadequate treatment n = 80 (%)</td><td>p</td></tr><t... | <table><tr><td>Characteristics</td><td></td><td>HAP (n = 94)</td><td></td><td></td><td>VAP (n = 117)</td><td></td></tr><tr><td></td><td>Adequate treatment n = 43 (%)</td><td>Inadequate treatment n = 51 (%)</td><td>p</td><td>Adequate treatment n = 37 (%)</td><td>Inadequate treatment n = 80 (%)</td><td>p</td></tr><tr><td... | <table><tr><td>Characteristics</td><td></td><td>HAP (n = 94)</td><td></td><td></td><td>VAP (n = 117)</td><td></td></tr><tr><td></td><td>Adequate treatment n = 43 (%)</td><td>Inadequate treatment n = 51 (%)</td><td>p</td><td>Adequate treatment n = 37 (%)</td><td>Inadequate treatment n = 80 (%)</td><td>p</td></tr><tr><td... |
9136c937ab592bed6fe174cf50c79e378c88febff661046adf19d716aa1845c8.png | simple | <table><tr><td>Characteristic</td><td>cv-lysozyme-3</td><td>cv-lysozyme-1*</td><td>cv-lysozyme-2**</td></tr><tr><td><underline>Lysozyme activity</underline></td><td></td><td></td><td></td></tr><tr><td> Optimal pH</td><td>7.5-8.5</td><td>5.5-6.5</td><td>5.5-6.5</td></tr><tr><td> Optimal ionic strength (I)</td><td>0.005-... | <table><tr><td>Characteristic</td><td>cv-lysozyme-3</td><td>cv-lysozyme-1*</td><td>cv-lysozyme-2**</td></tr><tr><td>Lysozyme activity</td><td></td><td></td><td></td></tr><tr><td>Optimal pH</td><td>7.5-8.5</td><td>5.5-6.5</td><td>5.5-6.5</td></tr><tr><td>Optimal ionic strength (I)</td><td>0.005-0.01</td><td>0.18-0.20</t... | <table><tr><td>Molecular properties</td><td></td><td></td><td></td></tr><tr><td>MW (Dalton)b</td><td>17782.3</td><td>17861.0</td><td>12984.6</td></tr><tr><td>Theoretical pI</td><td>6.84 (7.12)</td><td>8.95</td><td>6.33</td></tr><tr><td>Amino acid sequence</td><td></td><td></td><td></td></tr><tr><td>Total amino acid num... |
735c4e9ba50dac2e3ad69463102f60ae0768721c90814dacd0e325cef86bf49b.png | complex | <table><tr><td></td><td colspan="3">Utilization of postnatal care</td><td></td></tr><tr><td></td><td></td><td colspan="2">Confidence interval</td><td></td></tr><tr><td>Characteristics</td><td>Odds ratio</td><td>Lower</td><td>Upper</td><td><i>p</i></td></tr><tr><td>Occupation</td><td></td><td></td><td></td><td></td></tr... | <table><tr><td></td><td colspan="3">Utilization of postnatal care</td><td></td></tr><tr><td></td><td></td><td colspan="2">Confidence interval</td><td></td></tr><tr><td>Characteristics</td><td>Odds ratio</td><td>Lower</td><td>Upper</td><td>p</td></tr><tr><td>Occupation</td><td></td><td></td><td></td><td></td></tr><tr><t... | <table><tr><td>Second</td><td>3.21</td><td>0.82</td><td>12.52</td><td>0.093</td></tr><tr><td>Middle</td><td>3.24</td><td>0.75</td><td>13.94</td><td>0.115</td></tr><tr><td>Fourth</td><td>7.03</td><td>1.87</td><td>26.45</td><td>0.004</td></tr><tr><td>Highest</td><td>7.12</td><td>1.84</td><td>27.95</td><td>0.005</td></tr>... |
8c968fbd1242c061c46c83acc102d35fceabe8143ddc31c65eed6211430d50db.png | complex | <table><tr><td></td><td colspan="3">Placebo</td><td colspan="3">TOL ER</td></tr><tr><td></td><td>< 65 years (<i>n</i> = 1171)</td><td>65–74 years (<i>n</i> = 477)</td><td>≥ 75 years (<i>n</i> = 288)</td><td>< 65 years (<i>n</i> = 1360)</td><td>65–74 years (<i>n</i> = 582)</td><td>≥ 75 year... | <table><tr><td></td><td colspan="3">Placebo</td><td colspan="3">TOL ER</td></tr><tr><td></td><td>< 65 years (n = 1171)</td><td>65–74 years (n = 477)</td><td>≥ 75 years (n = 288)</td><td>< 65 years (n = 1360)</td><td>65–74 years (n = 582)</td><td>≥ 75 years (n = 285)</td></tr><tr><td colspan="7">Discontinuations, n (%)<... | <table><tr><td></td><td colspan="3">Placebo</td><td colspan="3">TOL ER</td></tr><tr><td></td><td>< 65 years (n = 1171)</td><td>65–74 years (n = 477)</td><td>≥ 75 years (n = 288)</td><td>< 65 years (n = 1360)</td><td>65–74 years (n = 582)</td><td>≥ 75 years (n = 285)</td></tr><tr><td>ge</td><td></td><td>65–74</td><td></... |
715b9c2c2641cb5f363cf80646ab029f190c39f0eebd98d11b0edbab081afb2a.png | complex | <table><tr><td></td><td></td><td colspan="2"><i>6 MeV</i></td><td colspan="2"><i>9 MeV</i></td><td colspan="2"><i>12 MeV</i></td><td colspan="2"><i>16 MeV</i></td><td colspan="2"><i>20 MeV</i></td></tr><tr><td><i>Cone</i></td><td><i>Depth</i></td><td><i>Measured</i></td><td><i>eMC</i></td><td><i>Measured</i></td><td><i... | <table><tr><td></td><td></td><td colspan="2">6 MeV</td><td colspan="2">9 MeV</td><td colspan="2">12 MeV</td><td colspan="2">16 MeV</td><td colspan="2">20 MeV</td></tr><tr><td>Cone</td><td>Depth</td><td>Measured</td><td>eMC</td><td>Measured</td><td>eMC</td><td>Measured</td><td>eMC</td><td>Measured</td><td>eMC</td><td>Me... | <table><tr><td>10.0</td><td>dmax</td><td>22.1</td><td>21.6</td><td>24.0</td><td>24.0</td><td>25.7</td><td>26.3</td><td>20.6</td><td>21.3</td><td>12.3</td><td>13.3</td></tr><tr><td>15.0</td><td>dmax</td><td>22.5</td><td>21.3</td><td>23.8</td><td>24.2</td><td>26.0</td><td>26.6</td><td>20.5</td><td>22.1</td><td>12.1</td><... |
a8f16c10b17c79c0ec52e9b078006439b8ee193a43ce4e9d8f9a6db4136a6b27.png | complex | <table><tr><td> </td><td colspan="2">RIP A (ICMB 841-P3 × 863B-P2)</td><td colspan="2">RIP B (H 77/833-2 × PRLT 2/89-33)</td><td colspan="2">RIP C (81B-P6 × ICMP 451-P8)</td><td colspan="2">RIP D (PT 732B-P2 × P1449-2-P1)</td><td colspan="2">Consensus map</td></tr><tr><td>Linkage groups</td><td>No. ... | <table><tr><td></td><td colspan="2">RIP A (ICMB 841-P3 × 863B-P2)</td><td colspan="2">RIP B (H 77/833-2 × PRLT 2/89-33)</td><td colspan="2">RIP C (81B-P6 × ICMP 451-P8)</td><td colspan="2">RIP D (PT 732B-P2 × P1449-2-P1)</td></tr><tr><td>Linkage groups</td><td>No. of markers</td><td>Map length (cM)</td><td>No. of marke... | <table><tr><td colspan="2">Consensus map</td></tr><tr><td>No. of markers</td><td>Map length (cM)</td></tr><tr><td>29</td><td>147</td></tr><tr><td></td><td></td></tr><tr><td>30</td><td>193</td></tr><tr><td>17</td><td>94</td></tr><tr><td>17</td><td>87</td></tr><tr><td>22</td><td>134</td></tr><tr><td>32</td><td>113</td></... |
b8e3e66aefe2bdead05aaba70c36a96321b0a18a3131ae0f97b158b5f5e05a12.png | simple | <table><tr><td>Isolate name</td><td>rpoB<sup>a</sup></td><td>Spoligotype classification</td></tr><tr><td>R160</td><td>Ser531Leu</td><td>LCC</td></tr><tr><td>R376</td><td>Ser531Leu</td><td>Haarlem</td></tr><tr><td>R458</td><td>Ser531Leu</td><td>Unknown/unique</td></tr><tr><td>R486</td><td>Leu533Pro</td><td>Beijing</td><... | <table><tr><td>Isolate name</td><td>rpoBa</td><td>Spoligotype classification</td></tr><tr><td>R160</td><td>Ser531Leu</td><td>LCC</td></tr><tr><td>R376</td><td>Ser531Leu</td><td>Haarlem</td></tr><tr><td>R458</td><td>Ser531Leu</td><td>Unknown/unique</td></tr><tr><td>R486</td><td>Leu533Pro</td><td>Beijing</td></tr><tr><td... | <table><tr><td>R1035</td><td>Ser531Leu</td><td>LAM</td></tr><tr><td>R1415</td><td>His526Tyr</td><td>Beijing</td></tr></table> |
65e973fe40fc911e5d75427cbe235d2568b79c130060905d8d627dd12ec234b1.png | complex | <table><tr><td rowspan="2">Gene</td><td>Forward primer (3′-5′)</td><td>Product length (bp)</td><td rowspan="2">NCBI Genbank</td><td rowspan="2">Slope</td><td rowspan="2">R<sup>2#</sup></td><td rowspan="2">Efficiency*</td></tr><tr><td>Reverse primer (5′-3′)</td><td> </td></tr><tr><td colspan="7">... | <table><tr><td rowspan="2">Gene</td><td>Forward primer (3′-5′)</td><td>Product length (bp)</td><td rowspan="2">NCBI Genbank</td><td rowspan="2">Slope</td><td rowspan="2">R2#</td></tr><tr><td>Reverse primer (5′-3′)</td><td></td></tr><tr><td colspan="6">Reference genes</td></tr><tr><td rowspan="2">ATP5G1</td><td>CAGTCACC... | <table><tr><td rowspan="2">Efficiency*</td></tr><tr></tr><tr><td>Reference genes</td></tr><tr><td rowspan="2">1.96</td></tr><tr></tr><tr><td rowspan="2">1.89</td></tr><tr></tr><tr><td rowspan="2">1.88</td></tr><tr></tr><tr><td>Target genes</td></tr><tr><td rowspan="2">1.95</td></tr><tr></tr><tr><td rowspan="2">1.99</td... |
cc078399ea8850505ef65eafd3891e399f5a5f262bfabc63d6bd7d132aae9780.png | complex | <table><tr><td>OTU</td><td>No. of clones</td><td>Phylogenetic class</td><td>Closest cultivated species (% similarity)</td></tr><tr><td colspan="4">Bioreactor for CH<sub>4</sub> production</td></tr><tr><td><i>Archaea</i></td><td></td><td></td><td></td></tr><tr><td> MET-BR-A01</td><td>49</td><td><i>Methanobacteria</i></t... | <table><tr><td>OTU</td><td>No. of clones</td><td>Phylogenetic class</td><td>Closest cultivated species (% similarity)</td></tr><tr><td colspan="4">Bioreactor for CH4 production</td></tr><tr><td>Archaea</td><td></td><td></td><td></td></tr><tr><td>MET-BR-A01</td><td>49</td><td>Methanobacteria</td><td>Methanothermobacter ... | <table><tr><td>OTU</td><td>No. of clones</td><td>Phylogenetic class</td><td>Closest cultivated species (% similarity)</td></tr><tr><td>Total</td><td>90</td><td></td><td></td></tr><tr><td colspan="4">Bioreactor for H2 production</td></tr><tr><td>Bacteria</td><td></td><td></td><td></td></tr><tr><td>HYD-BR-B01</td><td>47<... |
24d7823532ef34ee245768024dafb0337b1264f2aef69b35d752cffb75e9eb92.png | simple | <table><tr><td></td><td>Average (in days)</td><td>Within 1 week (in %)</td><td>Within 1 month (in %)</td><td>Within 3 months (in %)</td></tr><tr><td>All scientific fields</td><td>39</td><td>15</td><td>61</td><td>92</td></tr><tr><td>General</td><td>40</td><td>14</td><td>58</td><td>92</td></tr><tr><td>Natural sciences</t... | <table><tr><td></td><td>Average (in days)</td><td>Within 1 week (in %)</td><td>Within 1 month (in %)</td><td>Within 3 months (in %)</td></tr><tr><td>All scientific fields</td><td>39</td><td>15</td><td>61</td><td>92</td></tr><tr><td>General</td><td>40</td><td>14</td><td>58</td><td>92</td></tr><tr><td>Natural sciences</t... | <table><tr><td></td><td>Average (in days)</td><td>Within 1 week (in %)</td><td>Within 1 month (in %)</td><td>Within 3 months (in %)</td></tr><tr><td>Engineering</td><td>32</td><td>18</td><td>71</td><td>95</td></tr><tr><td>Mathematics and Computer sciences</td><td>33</td><td>18</td><td>69</td><td>95</td></tr><tr><td>Med... |
407bce523f792fa4dd730104257daf7818102117bb68c6bff75d637e4c18b45f.png | complex | <table><tr><td></td><td colspan="2">MAP-tau expression</td><td></td></tr><tr><td>Variable</td><td>Low (%) (AQUA score < 462)</td><td>High (%) (AQUA score > 462)</td><td><i>P* </i></td></tr><tr><td>Menopausal status</td><td></td><td></td><td></td></tr><tr><td> Premenopausal</td><td>108 (22.8)</td><td>31 (6.5)</td>... | <table><tr><td></td><td>MAP-tau expression</td></tr><tr><td>Variable</td><td>Low (%) (AQUA score < 462)</td></tr><tr><td>Menopausal status</td><td></td></tr><tr><td>Premenopausal</td><td>108 (22.8)</td></tr><tr><td>Postmenopausal</td><td>265 (55.9)</td></tr><tr><td>Tumor size</td><td></td></tr><tr><td>< 2 cm</td><td>12... | <table><tr><td>MAP-tau expression</td><td></td></tr><tr><td>High (%) (AQUA score > 462)</td><td>P*</td></tr><tr><td></td><td></td></tr><tr><td>31 (6.5)</td><td>0.734</td></tr><tr><td>70 (14.8)</td><td></td></tr><tr><td></td><td></td></tr><tr><td>31 (7.1)</td><td>0.535</td></tr><tr><td>50 (11.4)</td><td></td></tr><tr><t... |
ccb14d5a0be626201e2d182de2864135bed3fc8a518074ff78e02c7741d56290.png | complex | <table><tr><td>Type or gene involved</td><td>Number</td><td>Mean, kb</td><td>Range, kb</td></tr><tr><td colspan="4">Copy number losses : large</td></tr><tr><td> Interstitial deletion</td><td>18</td><td>5,070</td><td>1,048–16,837</td></tr><tr><td> Terminal deletion</td><td>14</td><td>5,273</td><td>1,218–13,5... | <table><tr><td>Type or gene involved</td><td>Number</td><td>Mean, kb</td><td>Range, kb</td></tr><tr><td colspan="4">Copy number losses : large</td></tr><tr><td>Interstitial deletion</td><td>18</td><td>5,070</td><td>1,048–16,837</td></tr><tr><td>Terminal deletion</td><td>14</td><td>5,273</td><td>1,218–13,593</td></tr><t... | <table><tr><td>Type or gene involved</td><td>Number</td><td>Mean, kb</td><td>Range, kb</td></tr><tr><td>Chromothripsis</td><td>1</td><td colspan="2">Loss: 134; Gains: 21,094</td></tr><tr><td>Subtotal</td><td>7</td><td colspan="2"></td></tr><tr><td>Total</td><td>142</td><td colspan="2"></td></tr></table> |
96ef8d874b7a18e0f8f7dfea76b37ada2697a903cbdfb539991c5447621173fb.png | complex | <table><tr><td colspan="2">Age group of children (months)</td><td colspan="2">Rotavirus status of Children</td><td></td><td></td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td><td>P-value</td></tr><tr><td>0-6</td><td>count</td><td>2</td><td>8</td><td>10</td><td></td></tr><tr><td></td><td>% o... | <table><tr><td colspan="2">Age group of children (months)</td><td colspan="2">Rotavirus status of Children</td><td></td><td></td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td><td>P-value</td></tr><tr><td>0-6</td><td>count</td><td>2</td><td>8</td><td>10</td><td></td></tr><tr><td></td><td>% o... | <table><tr><td colspan="2">Age group of children (months)</td><td colspan="2">Rotavirus status of Children</td><td></td><td></td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td><td>P-value</td></tr><tr><td>Total</td><td>count</td><td>22</td><td>138</td><td>160</td><td></td></tr><tr><td></td><... |
3b6dbc0d8bf64f00c1a079eaba11c4cf06952805b789ca64ebdb5e61e5ffdeb7.png | complex | <table><tr><td>Dataset</td><td></td><td>#Subjects</td><td>#Case</td><td>Platform</td><td>#SNPs</td></tr><tr><td>Croatia</td><td><i>(Before QC)</i></td><td>306</td><td>103</td><td>Illumina 550 K</td><td>561,466</td></tr><tr><td></td><td><i>(After QC)</i></td><td>305</td><td>103</td><td></td><td>489,200</td></tr><tr><td>... | <table><tr><td>Dataset</td><td></td><td>#Subjects</td><td>#Case</td><td>Platform</td></tr><tr><td>Croatia</td><td>(Before QC)</td><td>306</td><td>103</td><td>Illumina 550 K</td></tr><tr><td></td><td>(After QC)</td><td>305</td><td>103</td><td></td></tr><tr><td>NINDS</td><td>(Before QC)</td><td>542</td><td>0</td><td>Illu... | <table><tr><td>#SNPs</td></tr><tr><td>561,466</td></tr><tr><td>489,200</td></tr><tr><td>561,466</td></tr><tr><td>489,096</td></tr><tr><td>660,918</td></tr><tr><td>584,835</td></tr><tr><td></td></tr><tr><td>475,964</td></tr><tr><td>478,287</td></tr></table> |
d8257b36c26cdfcdfbf2e24c0d8f910257d8758e58a59ab6bd8ed33377e69397.png | simple | <table><tr><td>Species</td><td>Female</td><td>Male</td></tr><tr><td><i>Dichaetophora acutissima</i></td><td>20</td><td>25</td></tr><tr><td><i>Drosophila annulipes</i></td><td>31</td><td>27</td></tr><tr><td><i>Drosophila bizonata</i></td><td>31</td><td>31</td></tr><tr><td><i>Drosophila busckii</i></td><td>35</td><td>41<... | <table><tr><td>Species</td><td>Female</td><td>Male</td></tr><tr><td>Dichaetophora acutissima</td><td>20</td><td>25</td></tr><tr><td>Drosophila annulipes</td><td>31</td><td>27</td></tr><tr><td>Drosophila bizonata</td><td>31</td><td>31</td></tr><tr><td>Drosophila busckii</td><td>35</td><td>41</td></tr><tr><td>Drosophila ... | <table><tr><td>Drosophila lutescens</td><td>14</td><td>42</td></tr><tr><td>Drosophila rufa</td><td>41</td><td>41</td></tr><tr><td>Drosophila sternopleuralis</td><td>42</td><td>42</td></tr><tr><td>Drosophila suzukii</td><td>22</td><td>19</td></tr><tr><td>Hirtodrosophila sexvittata</td><td>41</td><td>41</td></tr><tr><td>... |
7afd6aac715c42448417c27835b5916ec1d0c1381ab0353dacfa16eac7e1d4ff.png | complex | <table><tr><td></td><td colspan="2"><i>Arabidopsis</i></td><td colspan="2">Rice</td></tr><tr><td>Origin of nat-siRNAs</td><td>Total</td><td>Unique</td><td>Total</td><td>Unique</td></tr><tr><td>Entire NATs</td><td>33,826</td><td>17,059</td><td>162,397</td><td>56,209</td></tr><tr><td> Introns in entire NATs</td><td>14,50... | <table><tr><td></td><td colspan="2">Arabidopsis</td><td colspan="2">Rice</td></tr><tr><td>Origin of nat-siRNAs</td><td>Total</td><td>Unique</td><td>Total</td><td>Unique</td></tr><tr><td>Entire NATs</td><td>33,826</td><td>17,059</td><td>162,397</td><td>56,209</td></tr><tr><td>Introns in entire NATs</td><td>14,500</td><t... | <table><tr><td></td><td colspan="2">Arabidopsis</td><td colspan="2">Rice</td></tr><tr><td>Origin of nat-siRNAs</td><td>Total</td><td>Unique</td><td>Total</td><td>Unique</td></tr><tr><td>Introns in OR of NATs</td><td>4,367</td><td>2,350</td><td>14,207</td><td>5,494</td></tr></table> |
9d38cca8061d6243bde68d74cb3d9885cbd84ec6e7ca92692af08a2785d6f8b4.png | simple | <table><tr><td>Sample</td><td>Potential (mV)</td><td>Dissolution Current Density at −400 mV (A cm<sup>−2</sup>)</td></tr><tr><td>No Exposure</td><td>−486.5</td><td>1.3 × 10<sup>−4</sup></td></tr><tr><td>Arica</td><td>−574.7</td><td>4.0 × 10<sup>−4</sup></td></tr><tr><td>Qui... | <table><tr><td>Sample</td><td>Potential (mV)</td></tr><tr><td>No Exposure</td><td>−486.5</td></tr><tr><td>Arica</td><td>−574.7</td></tr><tr><td>Quintero</td><td>−611.1</td></tr><tr><td>Laja</td><td>−515.0</td></tr><tr><td>Antarctic</td><td>−548.7</td></tr></table> | <table><tr><td>Dissolution Current Density at −400 mV (A cm−2)</td></tr><tr><td>1.3 × 10−4</td></tr><tr><td>4.0 × 10−4</td></tr><tr><td>12 × 10−4</td></tr><tr><td>1.6 × 10−4</td></tr><tr><td>4.6 × 10−4</td></tr></table> |
c6ff94937c8395b95b5267de471aa107e5dfbce476b3cffd00da47a0d0dac1ce.png | simple | <table><tr><td></td><td></td><td></td><td></td><td></td><td>It is likely that people who</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>have consumed bushmeat in</td></tr><tr><td>Variable</td><td>Response</td><td>Estimatea</td><td>SE</td><td>RVIb</td><td>the year prior to survey...</td></tr><tr><td>ARUc<... | <table><tr><td></td><td></td><td></td><td></td><td></td><td>It is likely that people who</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>have consumed bushmeat in</td></tr><tr><td>Variable</td><td>Response</td><td>Estimatea</td><td>SE</td><td>RVIb</td><td>the year prior to survey...</td></tr><tr><td>ARUc<... | <table><tr><td>Marital status</td><td>single</td><td>0.619</td><td>0.216</td><td>0.99</td><td>are from single parent households</td></tr><tr><td>Benefit from MUPd</td><td>yes</td><td>0.424</td><td>0.172</td><td>0.95</td><td>have benefitted from MUP</td></tr><tr><td>Well‐beinge</td><td>somewhat bad</td><td>0.030</td><td... |
0c2f52c568b147e3d125f48909fef0966f61a7ebf127564fde4ffe30b36ea5ac.png | simple | <table><tr><td>Gene</td><td>GC% <i>M. davidii</i></td><td>GC% <i>P. alecto</i></td><td>Gene length <i>M. davidii</i></td><td>Gene length <i>P. alecto</i></td></tr><tr><td><i>IKZF1</i></td><td>49.6</td><td>53.2 / 51.5</td><td>1908</td><td>228/816</td></tr><tr><td><i>GPSM1</i></td><td>49.1</td><td>65.4</td><td>705</td><t... | <table><tr><td>Gene</td><td>GC% M. davidii</td><td>GC% P. alecto</td></tr><tr><td>IKZF1</td><td>49.6</td><td>53.2 / 51.5</td></tr><tr><td>GPSM1</td><td>49.1</td><td>65.4</td></tr><tr><td>SPRR1</td><td>44.0</td><td>47.1</td></tr></table> | <table><tr><td>Gene length M. davidii</td><td>Gene length P. alecto</td></tr><tr><td>1908</td><td>228/816</td></tr><tr><td>705</td><td>2118</td></tr><tr><td>339</td><td>342</td></tr></table> |
e58fa7f6e0307889a412ae9e84d581309b93e22f92d6aeb79e9141f69a613a1f.png | complex | <table><tr><td> </td><td> </td><td colspan="2">All subjects (N = 15)</td><td> </td></tr><tr><td> </td><td> </td><td>Completed (N = 10)</td><td>Withdrawn (N = 5)</td><td> </td></tr><tr><td> </td><td>Mean (SD)</td><td> </td><td> </td><td>P</td></tr><tr><td>Age yrs</td><td>67.9 (9.4)</td><td>67.6 (10.9)</td><td>68.4 (6.3)... | <table><tr><td></td><td></td><td colspan="2">All subjects (N = 15)</td><td></td></tr><tr><td></td><td></td><td>Completed (N = 10)</td><td>Withdrawn (N = 5)</td><td></td></tr><tr><td></td><td>Mean (SD)</td><td></td><td></td><td>P</td></tr><tr><td>Age yrs</td><td>67.9 (9.4)</td><td>67.6 (10.9)</td><td>68.4 (6.3)</td><td>... | <table><tr><td></td><td></td><td colspan="2">All subjects (N = 15)</td><td></td></tr><tr><td></td><td></td><td>Completed (N = 10)</td><td>Withdrawn (N = 5)</td><td></td></tr><tr><td></td><td>Mean (SD)</td><td></td><td></td><td>P</td></tr><tr><td colspan="5">Sex</td></tr><tr><td>M</td><td>9 (60)</td><td>4 (40)</td><td>5... |
f65cebf232ae274a7c001723cec95926c153d278535f33cd379cfa4985d43397.png | complex | <table><tr><td rowspan="2" colspan="2">Clinicopathological parameters</td><td rowspan="2"><i>n</i></td><td colspan="2">NgBR expression</td><td rowspan="2"><i>P</i></td></tr><tr><td>Low</td><td>High</td></tr><tr><td colspan="2">Age (y)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤ 54</td><td>47</... | <table><tr><td rowspan="2" colspan="2">Clinicopathological parameters</td><td rowspan="2">n</td><td colspan="2">NgBR expression</td><td rowspan="2">P</td></tr><tr><td>Low</td><td>High</td></tr><tr><td colspan="2">Age (y)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤ 54</td><td>47</td><td>22</td><td>25... | <table><tr><td rowspan="2" colspan="2">Clinicopathological parameters</td><td rowspan="2">n</td><td colspan="2">NgBR expression</td><td rowspan="2">P</td></tr><tr><td>Low</td><td>High</td></tr><tr><td></td><td>> 5 cm</td><td>51</td><td>20</td><td>31</td><td></td></tr><tr><td colspan="2">Tumor number</td><td></td><td></... |
e25aacf3bda98cacea411243f473c944b7c231c54759e345574840dbffd21a66.png | complex | <table><tr><td></td><td colspan="3">Parameter</td></tr><tr><td>GROUP</td><td>Norepinephrine</td><td>Dopamine</td><td>Serotonin</td></tr><tr><td>Control</td><td>0.376 ± 0.07</td><td>1.45 ± 0.12</td><td>0.80 ± 0.115</td></tr><tr><td>Leaded gasoline</td><td>0.47 ± 0.086 a*</td><td>1.71 ± 0.14 a*</... | <table><tr><td></td><td colspan="3">Parameter</td></tr><tr><td>GROUP</td><td>Norepinephrine</td><td>Dopamine</td><td>Serotonin</td></tr><tr><td>Control</td><td>0.376 ± 0.07</td><td>1.45 ± 0.12</td><td>0.80 ± 0.115</td></tr></table> | <table><tr><td></td><td colspan="3">Parameter</td></tr><tr><td>Leaded gasoline</td><td>0.47 ± 0.086 a*</td><td>1.71 ± 0.14 a*</td><td>0.60 ± 0.043 a**</td></tr><tr><td>Unleaded gasoline</td><td>0.41 ± 0.036</td><td>1.35 ± 0.24 b**</td><td>0.385 ± 0.057 a*** b**</td></tr></table> |
6c6c7cb22b78adeb384a3d258920c2d7cf5be3d8745656a38f625a9ceed19014.png | simple | <table><tr><td>MIGS ID</td><td>Characteristic</td><td>Details</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>2kb (pUC19) and 40kb (pcc1FOS) Sanger and 454 standard libraries</td></tr><tr><td>MIGS-29</td><td>Sequencing platform</td><td>ABI-3730, 454 GS FLX Titanium</td></tr><tr><td>MIGS-31.2</td><td>Sequencing ... | <table><tr><td>MIGS ID</td><td>Characteristic</td><td>Details</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>2kb (pUC19) and 40kb (pcc1FOS) Sanger and 454 standard libraries</td></tr><tr><td>MIGS-29</td><td>Sequencing platform</td><td>ABI-3730, 454 GS FLX Titanium</td></tr></table> | <table><tr><td>MIGS-31.2</td><td>Sequencing coverage</td><td>1.1× Sanger 40kb insert, 31.3× pyrosequencing</td></tr><tr><td>MIGS-31</td><td>Finishing Quality</td><td>Finished</td></tr><tr><td>MIGS-30</td><td>Assembler</td><td>gsAssembler (Newbler) version 2.5.3</td></tr><tr><td>MIGS-32</td><td>Gene calling method</td><... |
2b8211cb2061ac5f9536a54165c10133d89ce53a637cf3bc630e3a78d6692ad4.png | simple | <table><tr><td>Criteria</td><td>Percentage</td></tr><tr><td>WHO</td><td>61.43%</td></tr><tr><td>Not sure</td><td>17.14%</td></tr><tr><td>ADA</td><td>12.38%</td></tr><tr><td>IADPS</td><td>9.05%</td></tr></table> | <table><tr><td>Criteria</td><td>Percentage</td></tr><tr><td>WHO</td><td>61.43%</td></tr><tr><td>Not sure</td><td>17.14%</td></tr><tr><td></td><td>12.38%</td></tr></table> | <table><tr><td>ADA</td><td></td></tr><tr><td>IADPS</td><td>9.05%</td></tr></table> |
10722a89f5df707a39e8ff980fed13741e27fdd09ec7192a4593b9c8b2fb8f11.png | complex | <table><tr><td rowspan="2"></td><td colspan="5">Coefficient of drug interaction (CDI)</td></tr><tr><td>Etoposide</td><td>Epirubicin</td><td>Doxorubicin</td><td>Vincristine</td><td>Colchicine</td></tr><tr><td>Ad5GS3</td><td>0.27</td><td>0.31</td><td>0.33</td><td>0.89</td><td>0.78</td></tr><tr><td>Ad5WS1</td><td>0.67</td... | <table><tr><td rowspan="2"></td><td colspan="4">Coefficient of drug interaction (CDI)</td></tr><tr><td>Etoposide</td><td>Epirubicin</td><td>Doxorubicin</td><td>Vincristine</td></tr><tr><td>Ad5GS3</td><td>0.27</td><td>0.31</td><td>0.33</td><td>0.89</td></tr><tr><td>Ad5WS1</td><td>0.67</td><td>0.46</td><td>0.88</td><td>0... | <table><tr><td>Coefficient of drug interaction (CDI)</td></tr><tr><td>Colchicine</td></tr><tr><td>0.78</td></tr><tr><td>0.81</td></tr></table> |
4d83408a2d327c3d5a07f5bad3d359a4918cd56585e0dff35ab181c472454cb7.png | complex | <table><tr><td>Exophily</td><td>No. caught</td><td>Exiting % (95% CI)</td><td>Median IQR exiting</td><td>OR</td><td>95% CI</td><td><i>P</i>-value</td><td><i>Z</i></td></tr><tr><td colspan="8">Control net</td></tr><tr><td> West African hut</td><td>587</td><td>35 (31–39)</td><td>2 (0.5–3)</td><td>1</td><td></... | <table><tr><td>Exophily</td><td>No. caught</td><td>Exiting % (95% CI)</td><td>Median IQR exiting</td><td>OR</td><td>95% CI</td><td>P-value</td><td>Z</td></tr><tr><td colspan="8">Control net</td></tr><tr><td>West African hut</td><td>587</td><td>35 (31–39)</td><td>2 (0.5–3)</td><td>1</td><td></td><td></td><td></td></tr><... | <table><tr><td>Ifakara hut</td><td>2067</td><td>64 (62–66)</td><td>23 (14–33.5)</td><td>4.18</td><td>3.18–5.51</td><td>< 0.0001</td><td>10.18</td></tr><tr><td colspan="8">Olyset® Net</td></tr><tr><td>West African hut</td><td>553</td><td>60 (56–64)</td><td>4 (2–11)</td><td>1</td><td></td><td></td><td></td></tr><tr><td>I... |
10ddc7ec107ac96bd78edac195b580cd288ba32bad503e18e523480ce01f7219.png | complex | <table><tr><td></td><td></td><td>WT</td><td>AS5<sup>ox</sup>-1</td><td>AS5<sup>ox</sup>-2</td></tr><tr><td colspan="2">*Days to Flowering from Planting</td><td>50.60 ± 1.43</td><td>53.80 ± 0.79</td><td>53.80 ± 0.79</td></tr><tr><td colspan="2">*Total Chlorophyll (g/m<sup>2</sup>) at Maturity</td><td>0.75... | <table><tr><td></td><td></td><td>WT</td><td>AS5ox-1</td><td>AS5ox-2</td></tr><tr><td colspan="2">*Days to Flowering from Planting</td><td>50.60 ± 1.43</td><td>53.80 ± 0.79</td><td>53.80 ± 0.79</td></tr><tr><td colspan="2">*Total Chlorophyll (g/m2) at Maturity</td><td>0.75 ±</td><td>0</td><td></td></tr></table> | <table><tr><td colspan="2"></td><td> 0.05</td><td>.69 ± 0.04</td><td>0.66 ± 0.04</td></tr><tr><td colspan="2">*Plant Height (cm)</td><td>99.97 ± 1.65</td><td>81.46 ± 2.36</td><td>86.66 ± 1.90</td></tr><tr><td colspan="2">*Shoot Fresh Weight (g)</td><td>101.69 ± 3.02</td><td>82.39 ± 3.29</td><td>83.21 ± 3.04</td></tr><t... |
d080e8458cde6eb9acab2dbfb6726e007dbb1e4dcd2a45a0cbdc7bf2806928d0.png | simple | <table><tr><td>Wired</td><td>Wireless</td></tr><tr><td>High bandwidth</td><td>Low-medium bandwidth</td></tr><tr><td>High performance</td><td>Higher latency</td></tr><tr><td>Robust</td><td>Interference</td></tr><tr><td>Reliable</td><td>Unreliable by nature</td></tr><tr><td>Installation expensive</td><td>Installation che... | <table><tr><td>Wired</td><td>Wireless</td></tr><tr><td>High bandwidth</td><td>Low-medium bandwidth</td></tr><tr><td>High performance</td><td>Higher latency</td></tr><tr><td>Robust</td><td>Interference</td></tr></table> | <table><tr><td>Reliable</td><td>Unreliable by nature</td></tr><tr><td>Installation expensive</td><td>Installation cheap</td></tr><tr><td>“Unlimited” resources</td><td>Low power, memory</td></tr><tr><td>Static network</td><td>Mobile network</td></tr><tr><td>Less security problems</td><td>More security problems</td></tr>... |
7627df30d784cf6a77ce32da2996aa5a3650489916451bec7e868a65891dd0b0.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td></td><td colspan="2">Physical activity</td></tr><tr><td>N</td><td>n<sup>d</sup> (%)</td><td>COR(95%CI)</td><td>AOR(95%CI)</td></tr><tr><td>Total</td><td>2063</td><td>2007 (97.3%)</td><td></td><td></td></tr><tr><td colspan="5">Age groups</td></tr><tr><td> ... | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td></td><td colspan="2">Physical activity</td></tr><tr><td>N</td><td>nd (%)</td><td>COR(95%CI)</td><td>AOR(95%CI)</td></tr><tr><td>Total</td><td>2063</td><td>2007 (97.3%)</td><td></td><td></td></tr><tr><td colspan="5">Age groups</td></tr><tr><td>18–29</td><t... | <table><tr><td>No education</td><td>396</td><td>381 (96.2)</td><td>1.0</td><td></td></tr><tr><td>Primary</td><td>1391</td><td>1359 (97.7)</td><td>1.67 (0.89–3.11)</td><td>−</td></tr><tr><td>Secondary and above</td><td>276</td><td>267 (97.7)</td><td>1.16 (0.50–2.71)</td><td>−</td></tr><tr><td colspan="5">Occupation</td>... |
431025477d31f6c9a3fe61b84830ab1a104e300e6c6d706583f13a4b5847c714.png | complex | <table><tr><td></td><td colspan="2">ALT (U/L)</td><td colspan="2">AST (U/L)</td><td colspan="2">Alkaline Phosphatase (U/L)</td><td colspan="2">Total Billirubin (mg/dL)</td></tr><tr><td></td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td></tr><tr><td>Baseline</td><td>27.07 ±... | <table><tr><td></td><td colspan="2">ALT (U/L)</td><td colspan="2">AST (U/L)</td><td colspan="2">Alkaline Phosphatase (U/L)</td><td colspan="2">Total Billirubin (mg/dL)</td></tr></table> | <table><tr><td></td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td></tr><tr><td>Baseline</td><td>27.07 ± 13.97</td><td>28.84 ± 15.00</td><td>25.2 ± 11.44</td><td>23.33 ± 13.00</td><td>66.2 ± 37.00</td><td>71.88 ± 41.00</td><td>0.75 ± 0.26</td><td>0.77 ± 0.40</td></tr><tr><td>Mon... |
76e52396f436a46fec2f1895e5b61e018c4a9c44b4d903392f6ddd7c2bea52af.png | complex | <table><tr><td>Dose, Subgroup (n at final visit)</td><td>Physical ComponentSummary</td><td>Mental ComponentSummary</td><td>Mental HealthDomain</td></tr><tr><td colspan="4">Elderly</td></tr><tr><td colspan="4">1 mg, with psychiatric disorders (n = 37)<sup>a</sup></td></tr><tr><td>Baseline</td><td>40.9 (15.9)</td><td>43.... | <table><tr><td>Dose, Subgroup (n at final visit)</td><td>Physical ComponentSummary</td><td>Mental ComponentSummary</td><td>Mental HealthDomain</td></tr><tr><td colspan="4">Elderly</td></tr><tr><td colspan="4">1 mg, with psychiatric disorders (n = 37)a</td></tr><tr><td>Baseline</td><td>40.9 (15.9)</td><td>43.6 (9.9)</td... | <table><tr><td>Dose, Subgroup (n at final visit)</td><td>Physical ComponentSummary</td><td>Mental ComponentSummary</td><td>Mental HealthDomain</td></tr><tr><td>Final visit (LOCF)</td><td>42.4 (12.2)</td><td>50.8 (10.9)</td><td>47.3 (11.2)</td></tr><tr><td>Change from baseline</td><td>1.5 (10.4)</td><td>6.8 (11.2)*</td>... |
bf8717435e25f4921fbbccc8d062ad427eea9501c31f7fedbaa3b3fcedf9c7ad.png | simple | <table><tr><td>Training section</td><td>Examples for tasks</td></tr><tr><td>Planning strategies</td><td>Shopping lists, key search of the BADS subscales, to get items out of a bottle, special wooden 3-dimensional jig saw </td></tr><tr><td>Mnemonics</td><td>Using memory hooks, writing of suitable mnemonics, and planning... | <table><tr><td>Training section</td></tr><tr><td>Planning strategies</td></tr><tr><td>Mnemonics</td></tr><tr><td>Decision making</td></tr><tr><td>Set shifting</td></tr><tr><td>Calculation</td></tr><tr><td>Navigational skills</td></tr><tr><td>Information speed processing</td></tr><tr><td>Summary</td></tr><tr><td>Concent... | <table><tr><td>Examples for tasks</td></tr><tr><td>Shopping lists, key search of the BADS subscales, to get items out of a bottle, special wooden 3-dimensional jig saw</td></tr><tr><td>Using memory hooks, writing of suitable mnemonics, and planning where to place them</td></tr><tr><td>Computer tasks, painting</td></tr>... |
81c84f70c8501db144c63e5a51e12df4157abeb8031fc7d5bf521a751b15544c.png | simple | <table><tr><td>Gene</td><td></td><td>N</td><td>Mean ± SD</td><td>P-value (Mann-Whitney test)</td></tr><tr><td>APC</td><td>Cases</td><td>11</td><td>2.06 ± 2.6</td><td>0.3</td></tr><tr><td></td><td>Controls</td><td>10</td><td>0.95 ± 1.31</td><td></td></tr><tr><td>ATM</td><td>Cases</td><td>9</td><td>0.5 ... | <table><tr><td>Gene</td><td></td><td>N</td><td>Mean ± SD</td><td>P-value (Mann-Whitney test)</td></tr><tr><td>APC</td><td>Cases</td><td>11</td><td>2.06 ± 2.6</td><td>0.3</td></tr><tr><td></td><td>Controls</td><td>10</td><td>0.95 ± 1.31</td><td></td></tr></table> | <table><tr><td>Gene</td><td></td><td>N</td><td>Mean ± SD</td><td>P-value (Mann-Whitney test)</td></tr><tr><td>ATM</td><td>Cases</td><td>9</td><td>0.5 ± 0.9</td><td>0.9</td></tr><tr><td></td><td>Controls</td><td>10</td><td>1.48 ± 2.2</td><td></td></tr></table> |
da80c8d6937df834221f4acfb1bfd6df8b616078fac06ea17f5fd30c3687d900.png | complex | <table><tr><td>25OHD, ng/mL</td><td colspan="2">25OHD ≤ 12</td><td colspan="2">13 < 25OHD ≤ 19</td><td colspan="2">20 < 25OHD ≤ 30</td><td colspan="2">25OHD > 30</td><td></td></tr><tr><td></td><td colspan="2"><i>n</i> = 2</td><td colspan="2"><i>n</i> = 9</td><td colspan="2"><i>n</i> = 15</td>... | <table><tr><td>25OHD, ng/mL</td><td colspan="2">25OHD ≤ 12</td><td colspan="2">13 < 25OHD ≤ 19</td><td colspan="2">20 < 25OHD ≤ 30</td><td colspan="2">25OHD > 30</td><td></td></tr><tr><td></td><td colspan="2">n = 2</td><td colspan="2">n = 9</td><td colspan="2">n = 15</td><td colspan="2">n = 24</td><td>p</td></tr><tr><t... | <table><tr><td>25OHD, ng/mL</td><td colspan="2">25OHD ≤ 12</td><td colspan="2">13 < 25OHD ≤ 19</td><td colspan="2">20 < 25OHD ≤ 30</td><td colspan="2">25OHD > 30</td><td></td></tr><tr><td></td><td colspan="2">n = 2</td><td colspan="2">n = 9</td><td colspan="2">n = 15</td><td colspan="2">n = 24</td><td>p</td></tr><tr><t... |
a54a838394a154ff1f6bf680a185903452ab31380bea4365204abcea306ba5b6.png | simple | <table><tr><td>Variable</td><td><i>N</i></td><td> </td></tr><tr><td>Age (yrs)</td><td>51</td><td>66.7 (12.0)</td></tr><tr><td>Sex (M/F)</td><td>51</td><td>26/25</td></tr><tr><td>MMSE</td><td>51</td><td>28.7 (1.4)</td></tr><tr><td>Education</td><td>51</td><td>5 (2)</td></tr><tr><td>NRS 50 kPa </td><td>51</td><td>1.2 (1.... | <table><tr><td>Variable</td><td>N</td><td></td></tr><tr><td>Age (yrs)</td><td>51</td><td>66.7 (12.0)</td></tr><tr><td>Sex (M/F)</td><td>51</td><td>26/25</td></tr><tr><td>MMSE</td><td>51</td><td>28.7 (1.4)</td></tr><tr><td>Education</td><td>51</td><td>5 (2)</td></tr><tr><td>NRS 50 kPa</td><td>51</td><td>1.2 (1.6)</td></... | <table><tr><td>Variable</td><td>N</td><td></td></tr><tr><td>Facial expressions 50 kPa</td><td>51</td><td>0.4 (0.6)</td></tr><tr><td>Facial expressions 200 kPa</td><td>50</td><td>0.7 (0.9)</td></tr><tr><td>Facial expressions 400 kPa</td><td>51</td><td>1.2 (1.4)</td></tr><tr><td>Stroop Word card (s)</td><td>51</td><td>55... |
1eba8e3be118026bfdca23e414f245d5a90c40e8f90d0bbf1af10836c4cd7c19.png | complex | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Blood flow (ml/min)<sup>a</sup></td><td>421 ± 42</td></tr><tr><td>Time of utilization (h)</td><td>30.6 ± 21.0</td></tr><tr><td>Access pressure (mmHg)<sup>a</sup></td><td>− 145 ± 14</td></tr><tr><td>Filter pressure (mmHg)<sup>a</sup></td><... | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Blood flow (ml/min)a</td><td>421 ± 42</td></tr></table> | <table><tr><td>Time of utilization (h)</td><td>30.6 ± 21.0</td></tr><tr><td>Access pressure (mmHg)a</td><td>− 145 ± 14</td></tr><tr><td>Filter pressure (mmHg)a</td><td>301 ± 19</td></tr><tr><td>Return pressure (mmHg)a</td><td>154 ± 21</td></tr><tr><td>Heparin bolus at insertion (IU)</td><td>3100 ± 1330</td></tr><tr><td... |
39c83d841fb7bfd067468ca10467a0cc29e7198e34f225c49b57669206070cfa.png | complex | <table><tr><td></td><td><i>N</i></td><td>Dog Owners(<i>n</i> = 43)</td><td>Non dog owners(<i>n</i> = 43)</td></tr><tr><td colspan="4">Match Characteristics</td></tr><tr><td> Gender (<i>N</i> female, %)</td><td>43</td><td>27 (63%)</td><td>27 (63%)</td></tr><tr><td> Age at start of study (years)</td><td>43</td><td>69.9 (... | <table><tr><td></td><td>N</td><td>Dog Owners(n = 43)</td><td>Non dog owners(n = 43)</td></tr><tr><td colspan="4">Match Characteristics</td></tr><tr><td>Gender (N female, %)</td><td>43</td><td>27 (63%)</td><td>27 (63%)</td></tr><tr><td>Age at start of study (years)</td><td>43</td><td>69.9 (± 4.1)</td><td>70.2 (± 4.1)</t... | <table><tr><td>king distance (km)</td><td>38/37</td><td>.1 ± (2.2)</td><td>± (2.6)</td></tr></table> |
3170b79440346a0705624ecc74b203247da82840a066b415aa809d7b5b39cd3b.png | simple | <table><tr><td>FAK location</td><td>Parameter</td><td>Correlation co-efficient</td><td>p-value</td></tr><tr><td>Vessels</td><td>Patient age</td><td>0.096</td><td>0.246</td></tr><tr><td> </td><td>Tumour size</td><td>0.089</td><td>0.28</td></tr><tr><td>Tumour cells</td><td>Patient age</td><td>-0.138</td><td>0.094</td></t... | <table><tr><td>FAK location</td><td>Parameter</td><td>Correlation co-efficient</td><td>p-value</td></tr><tr><td>Vessels</td><td>Patient age</td><td>0.096</td><td>0.246</td></tr><tr><td></td><td>Tumour size</td><td>0.089</td><td>0.28</td></tr><tr><td>Tumour cells</td><td>Patient age</td><td>-0.138</td><td>0.094</td></tr... | <table><tr><td></td><td>Tumour size</td><td>0.119</td><td>0.148</td></tr></table> |
9ba2149647106a1eff8b3da3427ad7637fa31d300b2883bc8b0b7ba18b153cd7.png | complex | <table><tr><td>Parameters</td><td>DMFT index</td><td><i>H</i></td><td>Found <i>p</i></td><td><i>p</i></td><td>Sig./N. sig.</td></tr><tr><td rowspan="3">Zn concentration, mmol/l (before stimulation)</td><td><1</td><td rowspan="3">2.54</td><td rowspan="3">0.28</td><td rowspan="3">>0.05</td><td rowspan="3">N. sig.</... | <table><tr><td>Parameters</td><td>DMFT index</td><td>H</td><td>Found p</td><td>p</td><td>Sig./N. sig.</td></tr><tr><td rowspan="3">Zn concentration, mmol/l (before stimulation)</td><td><1</td><td rowspan="3">2.54</td><td rowspan="3">0.28</td><td rowspan="3">>0.05</td><td rowspan="3">N. sig.</td></tr><tr><td>1–6</td></t... | <table><tr><td>Parameters</td><td>DMFT index</td><td>H</td><td>Found p</td><td>p</td><td>Sig./N. sig.</td></tr><tr><td rowspan="3">Zn concentration, mmol/l (after stimulation)</td><td><1</td><td rowspan="3">3.56</td><td rowspan="3">0.16</td><td rowspan="3">>0.05</td><td rowspan="3">N. sig.</td></tr><tr><td>1–6</td></tr... |
60bf0fbcab5d35144db59c08c161ee2f75a678ca8ab50fa43d31f9db35271dc8.png | simple | <table><tr><td>Parameter</td><td>FS (<i>n</i> = 848)</td><td>FGLS (<i>n</i> = 1556)</td><td>Total (<i>n</i> = 2404)</td></tr><tr><td>Gestational age at birth</td><td></td><td></td><td></td></tr><tr><td>< 28 weeks</td><td>2 (0.2)</td><td>1 (0.1)</td><td>3 (0.1)</td></tr><tr><td>28–32 weeks</td><td>3 (0.4)</td><... | <table><tr><td>Parameter</td><td>FS (n = 848)</td><td>FGLS (n = 1556)</td><td>Total (n = 2404)</td></tr><tr><td>Gestational age at birth</td><td></td><td></td><td></td></tr><tr><td>< 28 weeks</td><td>2 (0.2)</td><td>1 (0.1)</td><td>3 (0.1)</td></tr></table> | <table><tr><td>Parameter</td><td>FS (n = 848)</td><td>FGLS (n = 1556)</td><td>Total (n = 2404)</td></tr><tr><td>28–32 weeks</td><td>3 (0.4)</td><td>6 (0.4)</td><td>9 (0.4)</td></tr><tr><td>32–37 weeks</td><td>56 (6.6)</td><td>62 (4.0)</td><td>118 (4.9)</td></tr><tr><td>37–43 weeks</td><td>787 (92.8)</td><td>1487 (95.6)... |
306b33246fa9587d6f12dd881e0bedfe7a1c997f0960530eeefab8226fdf3382.png | simple | <table><tr><td>Experimental groups</td><td>n</td><td>DT days, Mean±SE</td><td>GD days, mean</td><td>Inhibition ratio (%)</td><td>CR number</td></tr><tr><td>Control</td><td>8</td><td>4.6±0.5</td><td></td><td>0</td><td>0</td></tr><tr><td>CDDP</td><td>8</td><td>10.6±1.21</td><td>5.5</td><td>33</td><td>0</td... | <table><tr><td>Experimental groups</td></tr><tr><td>Control</td></tr><tr><td>CDDP</td></tr><tr><td>EP</td></tr><tr><td>ECT</td></tr><tr><td>IR (3 Gy)</td></tr><tr><td>CDDP + IR (3 Gy)</td></tr><tr><td>EP + IR (3 Gy)</td></tr><tr><td>ECT + IR (3 Gy)</td></tr><tr><td>IR (5 Gy)</td></tr><tr><td>CDDP + IR (5 Gy)</td></tr><... | <table><tr><td>n</td><td>DT days, Mean±SE</td><td>GD days, mean</td><td>Inhibition ratio (%)</td><td>CR number</td></tr><tr><td>8</td><td>4.6±0.5</td><td></td><td>0</td><td>0</td></tr><tr><td>8</td><td>10.6±1.21</td><td>5.5</td><td>33</td><td>0</td></tr><tr><td>8</td><td>6.6±0.5</td><td>2.0</td><td>32</td><td>0</td></t... |
11d671bf1b59949d2b1b71e70c5d7951e5a07b513541a5e13897a7f298b2cc60.png | simple | <table><tr><td>Risk</td><td>Kupelian</td><td>D'Amico</td><td>Pound</td></tr><tr><td>Low</td><td>85%</td><td>83%</td><td>94-82%</td></tr><tr><td>Intermediate</td><td>65%</td><td>50%</td><td>72%</td></tr><tr><td>High</td><td>32%</td><td>28%</td><td>54%</td></tr></table> | <table><tr><td>Risk</td><td>Kupelian</td><td>D'Amico</td><td>Pound</td></tr><tr><td>Low</td><td>85%</td><td>83%</td><td>94-82%</td></tr><tr><td>Intermediate</td><td>65%</td><td>50%</td><td>72%</td></tr></table> | <table><tr><td>High</td><td>32%</td><td>28%</td><td>54%</td></tr></table> |
8d44b927d7ec7b8db4f9a71be8ac7a6a54ad7f3d65761a5a150ad2b598cd7a82.png | complex | <table><tr><td></td><td colspan="7">Days of pseudopregnancy</td></tr><tr><td>Cell Types</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr><tr><td>Luminal epithelium</td><td>+</td><td>+</td><td>+</td><td>+/-</td><td>+/-</td><td>+/-</td><td>+/-</td></tr><tr><td>Glandular epithelium</td><td>+/... | <table><tr><td></td><td colspan="7">Days of pseudopregnancy</td></tr><tr><td>Cell Types</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr></table> | <table><tr><td>Luminal epithelium</td><td>+</td><td>+</td><td>+</td><td>+/-</td><td>+/-</td><td>+/-</td><td>+/-</td></tr><tr><td>Glandular epithelium</td><td>+/-</td><td>+</td><td>+</td><td>+/-</td><td>+/-</td><td>+/-</td><td>+/-</td></tr><tr><td>Stromal cells</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-... |
21570fbf3703a9d6b4d370d906efd6327920ccd7194f78c8e6168990c7d4e65d.png | complex | <table><tr><td>Database name</td><td>Organization</td><td>Remarks</td><td>Relevance to investigation interests</td></tr><tr><td>National Health and Nutrition Examination Survey (NHANES)</td><td>CDC</td><td>Section on “Hearing/audiometry (AUQ) for 1 year and over, 1999-2012 with component or lab tests conducted on... | <table><tr><td>Database name</td><td>Organization</td><td>Remarks</td><td>Relevance to investigation interests</td></tr><tr><td>National Health and Nutrition Examination Survey (NHANES)</td><td>CDC</td><td>Section on “Hearing/audiometry (AUQ) for 1 year and over, 1999-2012 with component or lab tests conducted on origi... | <table><tr><td>Database name</td><td>Organization</td><td>Remarks</td><td>Relevance to investigation interests</td></tr><tr><td>System (BRFSS)</td><td>e Prevention and Health Promotion (NCCDPHP)</td><td>its activities 1998-2002, 2013; Veteran’s Status included, 2003-2008, 2010-2012</td><td>es</td></tr><tr><td>National ... |
8a531e2f1bcb4748bb5a3b10c2b3979f4d5a61d7780bc95527acf7241e407a6f.png | complex | <table><tr><td></td><td>Period</td><td colspan="2">Incidence Rate (per 100,000)</td><td colspan="2">Mortality Rate (per 100,000)</td><td colspan="2">Relative Survival Ratio (%)</td></tr><tr><td></td><td></td><td><i>Total</i></td><td><i>Rate (95% CI)</i></td><td><i>Total</i></td><td><i>Rate (95% CI)</i></td><td><i>N*</i... | <table><tr><td></td><td>Period</td><td colspan="2">Incidence Rate (per 100,000)</td><td colspan="2">Mortality Rate (per 100,000)</td><td colspan="2">Relative Survival Ratio (%)</td></tr><tr><td></td><td></td><td>Total</td><td>Rate (95% CI)</td><td>Total</td><td>Rate (95% CI)</td><td>N*</td><td>Ratio (95% CI)</td></tr><... | <table><tr><td>1973–1977</td><td>16</td><td>11.6 (5.7–21.1)</td><td>3</td><td>2.0 (0.4–5.8)</td><td>1.0</td><td>31.7 (4.7–75.8)</td></tr><tr><td>1978–1982</td><td>26</td><td>15.3 (9.6–23.3)</td><td>5</td><td>3.1 (0.9–7.5)</td><td>6.1</td><td>67.5 (35.9–95.0)</td></tr><tr><td>1983–1987</td><td>41</td><td>16.6 (11.7–22.8... |
164d0878a882db6911fcc702e7f7eae1ddbddb1e17852d63592ce4c552272983.png | simple | <table><tr><td>Genes</td><td>Forward primer (5′–3′)</td><td>Reverse primer (5′–3′)</td></tr><tr><td>m-PAX2</td><td>AAGCCCGGAGTGATTGGTG</td><td>CAGGCGAACATAGTCGGGTT</td></tr><tr><td>m-WT1</td><td>CAGTTCCCCAACCATTCCTT</td><td>AAGCTGGGAGGTCATTTGGT</td></tr><tr><td>m-Brachyury (Bry)</td>... | <table><tr><td>Genes</td><td>Forward primer (5′–3′)</td><td>Reverse primer (5′–3′)</td></tr><tr><td>m-PAX2</td><td>AAGCCCGGAGTGATTGGTG</td><td>CAGGCGAACATAGTCGGGTT</td></tr></table> | <table><tr><td>m-WT1</td><td>CAGTTCCCCAACCATTCCTT</td><td>AAGCTGGGAGGTCATTTGGT</td></tr><tr><td>m-Brachyury (Bry)</td><td>ACCCAGACTCGCCCAATTTT</td><td>GGAAAGCAGTGGCTGGTGAT</td></tr><tr><td>m-CD24</td><td>GTTGCACCGTTTCCCGGTAA</td><td>CCCCTCTGGTGGTAGCGTTA</td></tr><tr><td>m-Osr1</td><td>ATTCACCCTAAGCCAGAGATCA</td><td>AGG... |
c1106d2328412b83e37b5925f8b1fce443cb1a76ea3c0b28b07a658e76e29da1.png | complex | <table><tr><td></td><td></td><td>N (%) participants</td><td>N (%) valid days</td></tr><tr><td>Full sample</td><td></td><td>23,188 (100%)</td><td>158,784 (100%)</td></tr><tr><td>Sex</td><td>Male</td><td>8819 (38%)</td><td>62,745 (40%)</td></tr><tr><td></td><td>Female</td><td>14,369 (62%)<sup>†</sup></td><td>96,039... | <table><tr><td></td></tr><tr><td>Full sample</td></tr><tr><td>Sex</td></tr><tr><td></td></tr><tr><td>Age</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td rowspan="9">Country [No. studies]</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><t... | <table><tr><td></td><td>N (%) participants</td><td>N (%) valid days</td></tr><tr><td></td><td>23,188 (100%)</td><td>158,784 (100%)</td></tr><tr><td>Male</td><td>8819 (38%)</td><td>62,745 (40%)</td></tr><tr><td>Female</td><td>14,369 (62%)†</td><td>96,039 (60%)</td></tr><tr><td>5-6 years</td><td>1800 (8%)</td><td>7855 (5... |
99c465583576b13636199ed7d67c3eb02d103c8b6ab4fbdcb5750353f024094d.png | complex | <table><tr><td>Locus no.</td><td>Putative identification</td><td>Avg fold difference</td></tr><tr><td colspan="3">Mobile and extrachromosomal element functions: Transposon functions</td></tr><tr><td>PG0019</td><td>ISPg4 transposase</td><td>1.57</td></tr><tr><td>PG0050</td><td>ISPg4, transposase</td><td>1.81</td></tr><t... | <table><tr><td>Locus no.</td><td>Putative identification</td></tr><tr><td colspan="2">Mobile and extrachromosomal element functions: Transposon functions</td></tr><tr><td>PG0019</td><td>ISPg4 transposase</td></tr><tr><td>PG0050</td><td>ISPg4, transposase</td></tr><tr><td>PG0177</td><td>ISPg4, transposase</td></tr><tr><... | <table><tr><td>Avg fold difference</td></tr><tr><td>Mobile and extrachromosomal element functions: Transposon functions</td></tr><tr><td>1.57</td></tr><tr><td>1.81</td></tr><tr><td>1.87</td></tr><tr><td>2.18</td></tr><tr><td>1.80</td></tr><tr><td>2.20</td></tr><tr><td>1.60</td></tr><tr><td>1.98</td></tr><tr><td>2.11</t... |
afdb807f28daa793af6d9a075872bb54e6e11c770c8ad94bf6d2d1671a69afc0.png | simple | <table><tr><td>TCGA acronym</td><td>Cancer type</td><td>Paired samples</td><td>Unpaired tumor samples</td><td>Reference</td></tr><tr><td>BRCA</td><td>Breast invasive carcinoma</td><td>107</td><td>929</td><td>(3)</td></tr><tr><td>COAD</td><td>Colon adenocarcinoma</td><td>26</td><td>236</td><td>(1)</td></tr><tr><td>HNSC<... | <table><tr><td>TCGA acronym</td><td>Cancer type</td><td>Paired samples</td><td>Unpaired tumor samples</td><td>Reference</td></tr><tr><td>BRCA</td><td>Breast invasive carcinoma</td><td>107</td><td>929</td><td>(3)</td></tr><tr><td>COAD</td><td>Colon adenocarcinoma</td><td>26</td><td>236</td><td>(1)</td></tr><tr><td>HNSC<... | <table><tr><td>PRAD</td><td>Prostate adenocarcinoma</td><td>48</td><td>247</td><td>https://tcga-data.nci.nih.gov/</td></tr><tr><td>THCA</td><td>Thyroid carcinoma</td><td>58</td><td>439</td><td>https://tcga-data.nci.nih.gov/</td></tr></table> |
04b02d4cbcef3fc14af5957e66b15490c8c956801ff539891ba8683080aaede7.png | simple | <table><tr><td>Description</td><td>Number of features</td></tr><tr><td>Mean, range, interquartile range (<i>x</i>, <i>y</i>, <i>z</i>)</td><td>9</td></tr><tr><td>Moments: standard deviation, skew, kurtosis (<i>x</i>, <i>y</i>, <i>z</i>)</td><td>9</td></tr><tr><td>Histogram: bin counts of −2 to 1 <i>z</i>-scores (... | <table><tr><td>Description</td><td>Number of features</td></tr></table> | <table><tr><td>Mean, range, interquartile range (x, y, z)</td><td>9</td></tr><tr><td>Moments: standard deviation, skew, kurtosis (x, y, z)</td><td>9</td></tr><tr><td>Histogram: bin counts of −2 to 1 z-scores (x, y, z)</td><td>12</td></tr><tr><td>Derivative of moments: mean, standard deviation, skew, kurtosis (x, y, z)<... |
dd0aabcfbfabaf3ec42363239e0d6e02dcb71d033d44b9c2b3268750e407e174.png | complex | <table><tr><td rowspan="2">Gene Ontology (GO) Name</td><td rowspan="2">Number of Genes Involve</td><td rowspan="2">Fold Change</td><td colspan="2">Genes</td></tr><tr><td>Highly Expressed in Susceptible Group</td><td>Highly Expressed in Resistant Group</td></tr><tr><td>Negative regulation of transcription from RNA polym... | <table><tr><td rowspan="2">Gene Ontology (GO) Name</td><td rowspan="2">Number of Genes Involve</td><td rowspan="2">Fold Change</td><td colspan="2">Genes</td></tr><tr><td>Highly Expressed in Susceptible Group</td><td>Highly Expressed in Resistant Group</td></tr><tr><td>Negative regulation of transcription from RNA polym... | <table><tr><td>Innate immune response</td><td>9</td><td>1.4</td><td>DDX3X, JAK3, APOBEC3A, F12</td><td>CLEC4E, S100A12, ZBP1, IRF7, PGLYRP1</td></tr><tr><td>RNA polymerase II regulatory region seq-specific DNA binding</td><td>9</td><td>2.9</td><td>GATAD2A, MNT, PRDM15, SMAD3, TAL1, RXRA, RUNX3, ZNF8</td><td>-</td></tr>... |
27c8108eb21c3cb57f22c11f3fd0e66ade6b842f9838298f10fb74efaa095713.png | simple | <table><tr><td>Clinicopathological characteristic</td><td>Number (%)</td></tr><tr><td>Age, years</td><td></td></tr><tr><td> Median</td><td>70</td></tr><tr><td> Range</td><td>47–84</td></tr><tr><td>Sex</td><td></td></tr><tr><td> Male</td><td>30 (85.7)</td></tr><tr><td> Female</td><td>5 (14.3)</td></tr><tr><td>Smok... | <table><tr><td>Clinicopathological characteristic</td><td>Number (%)</td></tr></table> | <table><tr><td>Age, years</td><td></td></tr><tr><td>Median</td><td>70</td></tr><tr><td>Range</td><td>47–84</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>30 (85.7)</td></tr><tr><td>Female</td><td>5 (14.3)</td></tr><tr><td>Smoking status</td><td></td></tr><tr><td>Smoker</td><td>31 (88.6)</td></tr><tr><td>Ne... |
d3956e87417bfa8fd113c1c6544c0c14c6d27cbf6339f1c6f7eaa50d15cf0f42.png | complex | <table><tr><td rowspan="3"></td><td rowspan="3">RNA-Seq datasets comparison</td><td colspan="4">number of DEGs</td></tr><tr><td colspan="2">48 hai</td><td colspan="2">96 hai</td></tr><tr><td>up</td><td>down</td><td>up</td><td>down</td></tr><tr><td rowspan="4">2Hb8</td><td>R NIL <i>Fusarium</i> inoculated – R NIL ... | <table><tr><td rowspan="3"></td><td rowspan="3">RNA-Seq datasets comparison</td><td>number of DEGs</td></tr><tr><td>48 hai</td></tr><tr><td>up</td></tr><tr><td rowspan="4">2Hb8</td><td>R NIL Fusarium inoculated – R NIL mock inoculated (R_F/M)</td><td>11</td></tr><tr><td>M69 Fusarium inoculated – M69 mock inoculated (M6... | <table><tr><td colspan="3">number of DEGs</td></tr><tr><td>48 hai</td><td colspan="2">96 hai</td></tr><tr><td>down</td><td>up</td><td>down</td></tr><tr><td>21</td><td>415</td><td>192</td></tr><tr><td>167</td><td>1283</td><td>354</td></tr><tr><td>80</td><td>321</td><td>426</td></tr><tr><td>70</td><td>401</td><td>282</td... |
33705279fd0268b4c34c29459f6940c3265a6ab07393ff789b394804ea49e761.png | simple | <table><tr><td>Study name</td><td>Treatment arms</td><td>Time horizon (weeks)</td><td>Relapses</td><td>AE-related disc's</td><td>Non-AE-related disc's</td><td>Completers</td><td>Total Nr of patients</td><td>Nr of patients experiencing >7% weight gain (total Nr of patients)</td><td>Nr of patients experiencing EPS (to... | <table><tr><td>Study name</td><td>Treatment arms</td><td>Time horizon (weeks)</td><td>Relapses</td><td>AE-related disc's</td><td>Non-AE-related disc's</td><td>Completers</td><td>Total Nr of patients</td><td>Nr of patients experiencing >7% weight gain (total Nr of patients)</td><td>Nr of patients experiencing EPS (total... | <table><tr><td>Study name</td><td>Treatment arms</td><td>Time horizon (weeks)</td><td>Relapses</td><td>AE-related disc's</td><td>Non-AE-related disc's</td><td>Completers</td><td>Total Nr of patients</td><td>Nr of patients experiencing >7% weight gain (total Nr of patients)</td><td>Nr of patients experiencing EPS (total... |
00310c728dc432062bd97bfa5537fc9562ef8dee3af72104a22cfee0f20374eb.png | simple | <table><tr><td>Compound</td><td>RRI <sup>a</sup></td><td><i>S. boveanum </i></td><td><i>C. myrica</i></td><td><i>H. flagelliformis </i></td></tr><tr><td>Heptadecane</td><td>1698</td><td>-</td><td>-</td><td>4.1 ± 0.63</td></tr><tr><td>Tetradecanoic acid methyl ester</td><td>1718</td><td>8.1 ± 0.7</td><td>20.3 ... | <table><tr><td>Compound</td><td>RRI a</td><td>S. boveanum</td><td>C. myrica</td><td>H. flagelliformis</td></tr><tr><td>Heptadecane</td><td>1698</td><td>-</td><td>-</td><td>4.1 ± 0.63</td></tr><tr><td>Tetradecanoic acid methyl ester</td><td>1718</td><td>8.1 ± 0.7</td><td>20.3 ± 3.5</td><td>8.2 ± 0.9</td></tr><tr><td>9-(... | <table><tr><td>Compound</td><td>RRI a</td><td>S. boveanum</td><td>C. myrica</td><td>H. flagelliformis</td></tr><tr><td>9-(E)-octadecenoic acid methyl ester</td><td>2107</td><td>-</td><td>16.1 ± 2.0</td><td>7.9 ± 1.03</td></tr><tr><td>Octadecanoic acid methyl ester</td><td>2120</td><td>3.6 ± 0.7</td><td>11.9 ± 1.5</td><... |
cc1063edacd6ede8e7e5e3f556128a9da70bd93c2dcf19b470a2483087ace527.png | simple | <table><tr><td>Traits</td><td>TL</td><td>BL</td><td>BH</td><td>HL</td><td>BW</td></tr><tr><td>TL</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>BL</td><td>0.993</td><td>1</td><td></td><td></td><td></td></tr><tr><td>BH</td><td>0.849</td><td>0.841</td><td>1</td><td></td><td></td></tr><tr><td>HL</td><td>0.... | <table><tr><td>Traits</td><td>TL</td><td>BL</td><td>BH</td><td>HL</td><td>BW</td></tr></table> | <table><tr><td>TL</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>BL</td><td>0.993</td><td>1</td><td></td><td></td><td></td></tr><tr><td>BH</td><td>0.849</td><td>0.841</td><td>1</td><td></td><td></td></tr><tr><td>HL</td><td>0.782</td><td>0.782</td><td>0.723</td><td>1</td><td></td></tr><tr><td>BW</td><td>... |
1a03c25c391845f3d25d1b1a314a2e3240569f13d2760d2de327cee598f84951.png | simple | <table><tr><td>Farm location</td><td>Goat breed</td><td>Feed type</td></tr><tr><td>Farm 1 (F1), Hulu Langat, Selangor</td><td>Saanen cross (SC)</td><td>Napier grass silageBarley sproutsDatesMulberry leavesCorn grainGoat pellet</td></tr><tr><td>Farm 2 (F2), Banting, Selangor</td><td>Saanen pure (SP)</td><td>Napier grass... | <table><tr><td>Farm location</td><td>Goat breed</td><td>Feed type</td></tr><tr><td>Farm 1 (F1), Hulu Langat, Selangor</td><td>Saanen cross (SC)</td><td>Napier grass silageBarley sproutsDatesMulberry leavesCorn grainGoat pellet</td></tr><tr><td>Farm 2 (F2), Banting, Selangor</td><td>Saanen pure (SP)</td><td>Napier grass... | <table><tr><td>Farm location</td><td>Goat breed</td><td>Feed type</td></tr><tr><td>Farm 8 (F8), Jeram, Selangor</td><td>Jamnapari cross (JC)</td><td>Sarang Buaya grass (Ischaemum timorense Kunth)Mix bran</td></tr></table> |
dc93eee411db1e04d7d0f88678e57884295c8b19ed61ab12a41879cb45f24419.png | simple | <table><tr><td>Treament</td><td>G0/G1</td><td>S</td><td>G2/M</td><td>Sub G0</td></tr><tr><td>24 Hr Control</td><td>61.6 ± 0.4</td><td>11.6 ± 0.6</td><td>22.5 ± 0.6</td><td>1.5 ± 0.1</td></tr><tr><td>24 Hr Luteolin</td><td>49.3 ± 1.4c</td><td>12.7 ± 1.3</td><td>31.2 ± 0.9b</td><td>3.4 ... | <table><tr><td>Treament</td><td>G0/G1</td><td>S</td><td>G2/M</td><td>Sub G0</td></tr><tr><td>24 Hr Control</td><td>61.6 ± 0.4</td><td>11.6 ± 0.6</td><td>22.5 ± 0.6</td><td>1.5 ± 0.1</td></tr><tr><td>24 Hr Luteolin</td><td>49.3 ± 1.4c</td><td>12.7 ± 1.3</td><td>31.2 ± 0.9b</td><td>3.4 ± 0.2</td></tr><tr><td>24 Hr Contro... | <table><tr><td>24 Hr Luteolin Removed for 24 Hr</td><td>39.3 ± 0.7c</td><td>10.6 ± 0.3</td><td>29.0 ± 0.9a</td><td>8.8 ± 1.2c</td></tr><tr><td>24 Hr Control Removed for 48 Hr</td><td>83.7 ± 0.7</td><td>3.5 ± 0.4</td><td>8.8 ± 0.7</td><td>2.7 ± 0.4</td></tr><tr><td>24 Hr Luteolin Removed for 48 Hr</td><td>47.5 ± 0.5c</t... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.